The Cognitive and Neural Basis for Apathy in Frontotemporal Degeneration by Massimo, Lauren M.
University of Pennsylvania
ScholarlyCommons
Publicly Accessible Penn Dissertations
1-1-2014
The Cognitive and Neural Basis for Apathy in
Frontotemporal Degeneration
Lauren M. Massimo
University of Pennsylvania, lmassimo@nursing.upenn.edu
Follow this and additional works at: http://repository.upenn.edu/edissertations
Part of the Neuroscience and Neurobiology Commons, and the Nursing Commons
This paper is posted at ScholarlyCommons. http://repository.upenn.edu/edissertations/1360
For more information, please contact libraryrepository@pobox.upenn.edu.
Recommended Citation
Massimo, Lauren M., "The Cognitive and Neural Basis for Apathy in Frontotemporal Degeneration" (2014). Publicly Accessible Penn
Dissertations. 1360.
http://repository.upenn.edu/edissertations/1360
The Cognitive and Neural Basis for Apathy in Frontotemporal
Degeneration
Abstract
The syndrome of apathy, defined as a reduction in goal-directed behavior (GDB), has profound consequences
for morbidity and mortality in the patient and for family-caregiver burden. Apathy is one of the primary
neuropsychiatric syndromes associated with the disruption of the frontal-striatal system, but the behavioral
and biological mechanisms underlying apathy are not well understood. Apathy is especially prevalent in
behavioral variant frontotemporal degeneration (bvFTD). In a sample of 20 apathetic adults with bvFTD and
17 normal controls (NC), impairments in three components of GDB--initiation, planning and motivation--
were examined using a novel computerized reaction time test. Employing structural neuroimaging techniques,
I then examined the neural basis of GDB in these apathetic bvFTD participants. I found evidence that apathy
is associated with an impairment in any of the three GDB components. Initiation, planning, and motivation
each map onto three distinct brain regions in the frontal lobe that work together in a large-scale neural
network. Furthermore, I was able to identify participants with specific subtypes of apathy, depending on the
impaired GDB mechanism. I developed and submitted a proposal for continued study of the phenomenon;
the proposal was awarded. The long-term potential impact of this beginning program of research is profound
for patients with neurodegenerative disease, their caregivers, and families. Current treatment of apathy has
been hindered due to poor understanding of the mechanisms underlying this condition. This work will lead to
a better understanding of these mechanisms and structures fundamental to the behavior, and, with this
knowledge, tailored interventions can be designed and implemented by professional and lay caregivers. Thus,
a more precise characterization of apathy will allow providers to implement the most appropriate therapy for a
given patient.
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ABSTRACT 
THE COGNITIVE AND NEURAL BASIS FOR APATHY IN 
FRONTOTEMPORAL DEGENERATION 
Lauren M. Massimo 
Lois K. Evans 
The syndrome of apathy, defined as a reduction in goal-directed behavior (GDB), has 
profound consequences for morbidity and mortality in the patient and for family-
caregiver burden. Apathy is one of the primary neuropsychiatric syndromes associated 
with the disruption of the frontal-striatal system, but the behavioral and biological 
mechanisms underlying apathy are not well understood. Apathy is especially prevalent in 
behavioral variant frontotemporal degeneration (bvFTD). In a sample of 20 apathetic 
adults with bvFTD and 17 normal controls (NC), impairments in three components of 
GDB—initiation, planning and motivation—were examined using a novel computerized 
reaction time test. Employing structural neuroimaging techniques, I then examined the 
neural basis of GDB in these apathetic bvFTD participants. I found evidence that apathy 
is associated with an impairment in any of the three GDB components. Initiation, 
planning, and motivation each map onto three distinct brain regions in the frontal lobe 
that work together in a large-scale neural network. Furthermore, I was able to identify 
participants with specific subtypes of apathy, depending on the impaired GDB 
mechanism. I developed and submitted a proposal for continued study of the 
phenomenon; the proposal was awarded. The long-term potential impact of this 
beginning program of research is profound for patients with neurodegenerative disease, 
their caregivers, and families. Current treatment of apathy has been hindered due to poor 
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understanding of the mechanisms underlying this condition. This work will lead to a 
better understanding of these mechanisms and structures fundamental to the behavior, 
and, with this knowledge, tailored interventions can be designed and implemented by 
professional and lay caregivers. Thus, a more precise characterization of apathy will 
allow providers to implement the most appropriate therapy for a given patient. 
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CHAPTER 1: INTRODUCTION 
The syndrome of apathy, defined as a reduction in self-generated or voluntary 
behavior (Levy & Dubois, 2006), has profound consequences for morbidity and mortality 
in patients with neurodegenerative disease (ND) and contributes significantly to family 
caregiver burden (Butterfield, Cimino, Oelke, Hauser, & Sanchez-Ramos, 2010; Chio et 
al., 2010; Karttunen et al., 2010). Apathy is especially prevalent in behavioral variant 
Frontotemporal degeneration (bvFTD), where it is reported in up to 90.5% of mild-stage 
patients (Diehl-Schmid, Pohl, Perneczky, Forstl, & Kurz, 2006). 
FTD is the second most common young-onset ND (Ratnavalli, Brayne, Dawson, 
& Hodges, 2002; Rosso et al., 2003). Neuronal loss in the frontal and temporal lobes of 
the brain results in difficulty regulating social behavior (Massimo & Grossman, 2008). In 
the field of ND, abnormal social behavior includes a wide range of neuropsychiatric 
symptoms that are disruptive to social interaction (Massimo, Evans, & Benner, 2013). 
Abnormal social behavior is the hallmark symptom of bvFTD, with the syndrome of 
apathy being the most common, evident pervasively throughout the duration of the 
disease (Le Ber et al., 2006; Mendez, Lauterbach, & Sampson, 2008). Although apathy in 
bvFTD is a very common and significant problem, the mechanisms contributing to this 
behavior rarely have been studied. At present, no proven effective treatments exist for 
apathy, in part because the underlying dysfunction is not fully understood (Chase, 2011). 
Thus, the purpose of this study was to advance understanding of mechanisms 
contributing to apathy to improve outcomes for those suffering its consequences. 
The concept of goal-directed behavior (GDB) provides a useful model for 
examining the mechanisms underlying apathy. In neuroscience, GDB is used to 
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operationalize a broad spectrum of purposeful actions and their determinants (Brown & 
Pluck, 2000), related to the belief that when action a is taken, goal x may be obtained as a 
result. The GDB model was proposed by Levy and Dubois (2006) to improve 
understanding of the mechanisms that contribute to the loss of self-initiated behavior 
referred to as “apathy.” Despite urging from caregivers, pain, and risk of death, patients 
with apathy do not initiate GDB. 
Three distinct components of GDB are initiation, planning, and motivation 
(Brown & Pluck, 2000). Each component of GDB is supported by a distinct anatomic 
circuit centered on a specific portion of the prefrontal cortex. Apathy is hypothesized to 
emerge where there is dysfunction of any one of these components (Levy & Dubois, 
2006). Using neurobiological tools, such as quantitative brain imaging, to study patients 
with apathy strongly suggests an anatomic basis for the mechanisms contributing to 
apathy (Massimo et al., 2009; Rosen et al., 2005; Zamboni, Huey, Krueger, Nichelli, & 
Grafman, 2008). Therefore, I proposed to use the GDB model to examine the brain-
behavior relationships underlying apathy in bvFTD. Specifically, I conducted an 
empirical study that quantified difficulty with each component of GDB using a novel 
computerized reaction-time test, examined the distinct prefrontal neuroanatomical 
substrates of these impairments in an apathetic bvFTD sample using regression, and then 
related specific apathetic behaviors to grey matter atrophy and white matter integrity, 
quantified by magnetic resonance imaging (MRI). 
Study Significance 
The following case captures the problem this research addressed: 
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BJ is a 58-year-old female with FTD. Her husband notes that “it is impossible to 
get her going.” She sits and watches static on the television all day long and her 
husband rarely sees her move spontaneously. She has developed pressure ulcers 
because of her lack of movement: Neither urgent prompts from her husband nor 
the pressure ulcer associated pain has been successful in compelling her to move. 
Her husband is very distressed about his wife’s behavior and wants to know, 
“Why does she just sit there?” Of note, her Mini-Mental State Exam (MMSE) 
score is 28 of 30 (“no impairment”). 
BJ’s case demonstrates the significant problems that can occur when someone is 
apathetic. The goal of this research was to help answer questions about why apathy 
occurs in individuals with bvFTD. Apathy is a very common neuropsychiatric syndrome 
negatively affecting patient and caregiver outcomes (Chio et al., 2010; Karttunen et al., 
2010) including increased patient mortality (Vilalta-Franch, Calvo-Perxas, Garre-Olmo, 
Turro-Garriga, & Lopez-Pousa, 2013). Apathy is associated with a variety of undesirable 
consequences in patients, such as poor insight and poor cognitive performance (Chase, 
2011; Ishii, Weintraub, & Mervis, 2009; Pedersen, Alves, Aarsland, & Larsen, 2009; 
Pluck & Brown, 2002). The deficits observed in apathetic patients such as poor planning, 
poor motivation, and the inability to initiate even the simplest self-care activities 
contribute to functional deterioration (Pedersen, Alves, et al., 2009). These findings 
suggest that apathy contributes significantly to global decline and mortality, and support 
the need for its identification and proper management in at-risk patient populations. 
Caring for a person with apathy is challenging. The physical and emotional 
demands associated with performing many activities for persons with apathy are 
profound. High levels of depression, burden, and stress have been reported in caregivers 
of apathetic patients (Chio et al., 2010; Massimo et al., 2009). 
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Apathetic bvFTD patients, in particular, lack insight into their social difficulties 
and are unaware of the consequences of their behavior (Eslinger et al., 2005; Massimo, 
Libon, et al., 2013). Their caregivers often misinterpret apathy as a sign of oppositional 
or volitional behavior, leading to dissatisfaction with caregiving (Landes, Sperry, Strauss, 
& Geldmacher, 2001; Massimo, Evans, et al., 2013). A study of 53 spousal caregivers 
demonstrated that apathetic behavior had the greatest impact on the decline of the marital 
relationship (de Vugt et al., 2006). This impact has significant implications for caregiver 
burnout because it is the bond between caregiver and care recipient that sustains 
caregiving under adverse conditions (Wrubel & Folkman, 1997). 
Treatments for apathy have heretofore been ineffective. In a recent systematic 
review of pharmacological treatments, there was insufficient evidence to support the use 
of medications for the improvement of apathy in ND (Drijgers, Dujardin, Reijnders, 
Defebvre, & Leentjens, 2010). One reason for these failures may be the way apathy is 
currently conceptualized. That is, apathy is viewed homogeneously, as if derived simply 
from a lack of motivation (Marin, 1996). There is evidence to suggest several different 
mechanisms contribute to apathy, including deficits in initiation and planning, as well as 
motivation (Chow et al., 2009; Eslinger, Moore, Antani, Anderson, & Grossman, 2012; 
Levy & Dubois, 2006; Massimo et al., 2009). Additionally, there is neuroanatomical 
evidence to support a multicomponent approach to apathy. Several neuroimaging studies 
associate apathy with numerous regions in the frontal cortex (Massimo et al., 2009; 
Rosen et al., 2005; Zamboni et al., 2008). Mechanisms underlying apathy are 
qualitatively different, and, thus, may require distinct interventions. Knowledge of 
distinct subtypes of apathy would help explain treatment failures that may be due, at least 
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in part, to the attempt to treat all apathy with a single approach. For example, when 
apathy emerges in response to planning difficulties, there is benefit to be gained from 
structuring the activity in a simple way for the patient. For patients with impaired goal-
selection, modifications such as amplified lighting in a room may increase the reward 
potential of the environment (Ishii et al., 2009). Last, multisensory stimulation (MSS), a 
therapeutic approach that provides visual, auditory, tactile, and olfactory stimulation, may 
be helpful for patients with initiation difficulty (Baker et al., 2001); the use of MSS in a 
patient with planning difficulty, however, may worsen rather than improve apathy. 
Additionally, apathy is often ignored by clinicians because of patients’ lack of apparent 
distress (Butterfield et al., 2010). One of the primary obstacles in furthering the research 
in this area has been the absence of an empirically-based approach that can elucidate the 
mechanisms contributing to apathy. This research, thus, aimed to fill this gap by applying 
a model of GDB in persons with bvFTD where apathy is highly prevalent. This work, 
which attempted to understand the cognitive and neural basis for apathy, represents the 
first step to support the development of rational treatment for patients with various 
subtypes of apathy. 
The potential long-term impact of this work is significant. This research holds 
promise for changing the way in which nurses and other health professionals currently 
view, evaluate, and treat apathy in patients with ND, as well as in other neuropsychiatric 
conditions. The pathophysiological model resulting from this work, revealing several 
mechanisms contributing to apathy, may lead to improved treatment using tailored 
biobehavioral interventions that target the impairments in GDB. In addition to direct 
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clinical benefits, the knowledge gained from this work will advance neurocognitive 
models of social behavior.  Thus, The aims of this study were: 
Specific Aims 
Aim 1: To relate impairments in GDB (initiation, planning, and motivation) in 
bvFTD to distinct neuroanatomic regions in the prefrontal cortex. 
H1: Poor initiation is related to grey matter atrophy in the anterior cingulate 
cortex (ACC) and to reduced white matter integrity in the cingulum. 
H2: Poor planning is related to grey matter atrophy in the dorsolateral prefrontal 
cortex (dlPFC) and to reduced white matter integrity in the superior 
longitudinal fasciculus. 
H3: Poor motivation is related to grey matter atrophy in the orbital-frontal cortex 
(OFC) and to reduced white matter integrity in the uncinate fasciculus. 
Aim 2: To differentiate three apathetic subtypes based on impaired components of 
GDB in bvFTD using a novel computerized reaction time test (Philadelphia Apathy 
Computerized Test [PACT]) and to examine regional grey matter volume underlying 
these impairments. 
H1: Participants with bvFTD will have greater difficulty with initiation than 
normal controls (NC). Moreover, I will identify a subtype of bvFTD 
participants with a specific deficit of initiation who will have significantly 
slower initiation times on the simple condition of the PACT compared to NC. 
Participants with initiation difficulty will have significantly reduced ACC 
grey matter values compared to a control brain region. 
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H2: Participants with bvFTD will have greater difficulty with planning than NC. 
Moreover, I will identify a subtype of bvFTD participants with a specific 
planning deficit who will have significantly greater slowing on the complex 
planning condition, contrasted with the simpler planning condition of the 
PACT compared to NC. Participants with planning difficulty will have 
significantly reduced dlPFC grey matter values compared to a control brain 
region. 
H3: Participants with bvFTD will have greater difficulty with motivation than NC. 
Moreover, I will identify a subtype of bvFTD participants with a specific 
deficit of motivation who will fail to respond to penalizing motivators in the 
simple condition compared to NC. Participants with motivation difficulty will 
have significantly reduced OFC grey matter values compared to a control 
brain region. 
Aim 3: To develop a proposal, based on findings from Aims 1 and 2, which will 
improve understanding of apathy by examining mechanisms of longitudinal decline and 
neural compensation. 
GDB allows people to be independent in everyday task performance. This 
research advances models of social neuroscience by examining cognitive and neural 
bases to understand a key aspect of human behavior. Moreover, the results will help 
change the paradigm to assess and treat apathy in ND, leading to improved diagnostic 
accuracy and effective interventions. This outcome will greatly improve the ability of 
families, nurses, and other health professionals to manage a pervasive feature of ND. 
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Background 
Definition of apathy. The word apathy derives from the Greek word pathos or 
passion. It describes a state of indifference or inertia (Robert et al., 2009). Over time the 
concept of apathy has undergone changes in meaning, and remains vaguely defined and 
broadly applied (Chase, 2011). Sometimes described as a symptom of other disorders 
such as depression, Marin (1990) clarified the concept of apathy for medical purposes by 
proposing its definition as a lack of motivation. Marin suggested that apathy is a 
syndrome or dimension of behavior that results from psychiatric, neurologic, or medical 
disorders. One problem with Marin’s definition is that lack of motivation is not the only 
mechanism that contributes to apathetic behavior; “lack of motivation” is not easily 
quantifiable. In 2006, Levy and DuBois (2006) proposed to define apathy as the 
quantitative reduction of self-generated voluntary and purposeful GDB. Their definition 
informed the current study. From this perspective, it is possible to observe and measure 
the various mechanisms contributing to apathy. Furthermore, it may be possible to 
operationalize these underlying mechanisms and postulate “subtypes” of apathy based on 
impaired GDB. 
A new consensus for the clinical diagnosis of apathy in neurodegenerative 
conditions has been proposed by an international task force (Robert et al., 2009). To meet 
criteria, the patient must meet the following requirements: the core feature of diminished 
motivation must be present for at least 4 weeks, there must be a reduction in two of three 
domains, and there must be a functional impairment attributed to the behavior. Domain 1 
refers to reduced GDB, describing the loss of self-initiated behavior (e.g., starting a 
conversation) and loss of environment-stimulated behavior (e.g., responding to 
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conversation). Domain 2 refers to a reduction in goal-directed cognitive behavior, 
describing a loss of ideas and curiosity for new routines (e.g., recent news or social 
opportunities). Domain 3 refers to a reduction in emotion, describing a loss of 
spontaneous emotion or loss of emotional responsiveness to positive or negative stimuli 
(e.g., little reaction to exciting news). A reliable clinical diagnosis of apathy is necessary 
to identify its presence and to distinguish it from other clinical syndromes such as 
depression. These criteria, however, focus solely on clinical presentation of apathy. This 
dissertation goes beyond providing a clinical description of apathy; the intent is to 
understand the different mechanisms that underlie apathy so that meaningful treatment, 
based on specific impaired mechanisms, can be pursued. 
Thus, in this dissertation, I examined the GDB model, applied to apathy, to 
identify the underlying mechanisms (Aim 1), and I operationalized the underlying 
mechanisms to postulate “subtypes” of apathy (Aim 2). Last, the findings from Aims 1 
and 2 informed a proposal for future work in which I intend to examine the trajectory of 
apathy and identify factors that moderate the progression of this devastating 
neuropsychiatric syndrome (Aim 3). The literature for this chapter was selected from 
search results using CINAHL, EMBASE, Medline, PubMed, PsycINFO, Cochrane 
Reviews, and a hand search of the reference lists from articles. Selected articles included 
randomized-controlled trials, descriptive studies, and reviews. Although it may be useful 
to investigate neurochemistry as it relates to apathy, this area of inquiry was beyond the 
scope of this dissertation study. 
Hypothesized model of apathy. Apathy can be explained and examined as part 
of the concept of GDB. GDB is operationalized as a “broad spectrum of purposeful 
10 
	  
actions and their determinants, from the simplest movement to the most complex patterns 
of behavior” (Brown & Pluck, 2000, p. 416). This is related to the belief that when action 
a is taken, goal x may be obtained as a result. Central to GDB is the integration of the 
processes that influence a person to act (intention). According to the model, three 
processes (initiation, planning, and motivation) influence the intention to act. Although 
each step is necessary to achieve GDB, clinical observations of patients with ND suggest 
that these processes may not be sequential. In the hypothesized model, apathy arises 
when any one of these three processes is impaired. For example, patients who have 
profound impairments in the executive abilities needed to design and carry out plans of 
action may be motivated to engage in GDB, but their planning impairments make it 
difficult to engage in GDB. Therefore, it is likely that each process is independent and, 
when compromised, contributes to apathy. 
These three processes of GDB map onto three distinct networks of brain regions. 
In particular, neuroimaging studies in patients have linked apathy to specific regions in 
the prefrontal cortex, anterior cingulate, and basal ganglia. G. E. Alexander, DeLong, and 
Strick (1986) were first to describe the five circuits (two motor and three behavioral) 
linking the basal ganglia and frontal cortex. The three functional neuroanatomic loops in 
the frontal area (anterior cingulate circuit, dorsolateral prefrontal circuit, and orbitofrontal 
circuit) capture the information from internal and external environments needed to make 
a decision about possible actions to be performed, likely important to GDB. Each circuit 
is functionally separate and mediates in its own way. This dissertation study focused on 
the three functional neuroanatomic loops—anterior cingulate circuit, dlPFC circuit, and 
orbitofrontal circuit—and their relationship to initiation, planning, and motivation. 
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Frontotemporal degeneration. FTD is an ND that mainly affects the frontal and 
temporal lobes of the brain. This condition affects individuals at a young age, typically 
presenting in the fifth or sixth decade of life (Massimo & Grossman, 2008; Rosso et al., 
2003). FTD is recognized as the most common young onset dementia with prevalence 
ranging from 15–22 per 100,000 cases per year (Knopman & Roberts, 2011). These 
numbers are likely to be an underestimate, as the disorder is difficult to diagnose and 
requires a level of expertise in behavioral neurology. Clinically, bvFTD presents with 
difficulty regulating social behaviors such as disinhibition and apathy and a profound loss 
of insight (Rascovsky et al., 2011). One large autopsy-confirmed study demonstrated the 
frequency of behavioral symptoms in bvFTD to be between 59% to 84%, with apathy 
most frequent (Rascovsky et al., 2011). These behaviors significantly impact everyday 
functions and contribute to caregiver distress (Massimo et al., 2009; Mioshi & Hodges, 
2009). Thus, it is important to understand apathy for the optimal management of patients. 
Apathy in neurodegenerative disease. In addition to FTD, apathy is also 
common in other neurodegenerative disorders such as Alzheimer’s disease (AD), FTD, 
Lewy Body Disease, and Parkinson’s disease (PD; Clarke et al., 2008; Mega, Cummings, 
Fiorello, & Gornbein, 1996). In the AD population, the prevalence rate is between 51 and 
80% (Aharon-Peretz, Kliot, & Tomer, 2000; Di Iulio et al., 2010; Kaufer et al., 1998). 
The frequency of apathy in PD may also be substantial, as estimates of prevalence range 
from 12 to 70% (Aarsland et al., 2009; Pedersen, Larsen, Alves, & Aarsland, 2009; 
Starkstein et al., 1992). 
Abnormal social behavior is a hallmark of FTD. In particular, it has been 
suggested that apathy is the most prevalent behavior in FTD, occurring in up to 90.5% of 
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mild-stage patients and up to 100% of moderate and severe-stage patients in one study 
that evaluated the prevalence of behavioral disturbances in FTD (Diehl-Schmid et al., 
2006). Other authors also reported apathy to be the most common neuropsychiatric 
behavior in FTD (Massimo et al., 2009; Peters et al., 2006). Although apathy is often 
referenced as a behavior or symptom, this study examines apathy as a syndrome, which 
acknowledges heterogeneous behavioral processes and neuroanatomical mechanisms 
contributing to the clinical phenomenology. 
Evidence from previously reported work suggests that impairments in GDB are 
also present in bvFTD patients. Poor motivation may occur in these patients because they 
have decreased reactivity to positive and negative signals in social situations. Grossman 
and colleagues (2010) recently examined decreased reactivity by asking bvFTD patients 
to judge the acceptability of social situations. They found that bvFTD patients were 
particularly insensitive to the interpretation of negatively valenced features. Impaired 
executive function, a common finding in bvFTD, has also been associated with apathy in 
this group (Eslinger, Moore, Anderson, & Grossman, 2011; Eslinger et al., 2012). 
Impaired executive function may contribute to apathy because of the inability to carry out 
plans of action. Last, although poor initiation has not been explicitly examined in bvFTD, 
the anterior cingulate—an area that has been hypothesized to contribute to the loss of 
self-initiated thoughts or actions (Levy & Dubois, 2006)—is compromised in apathetic 
patients (Massimo et al., 2009). 
Depression and apathy are two distinct syndromes that are often confused. 
Symptoms that are common to both apathy and depression include hypersomnia and 
fatigue (Landes et al., 2001; Mega et al., 1996). Starkstein, Ingram, Garau, and Mizrahi 
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(2005) examined the differentiation of apathy and depression using factor analysis of the 
Hamilton Depression Scale. They found that dysphoric symptoms such as sad mood, guilt, 
suicidal ideation, anxiety, and insomnia loaded as sadness factors, suggesting these were 
more commonly found in a depressed patients. Other symptoms such as self-criticism and 
negative thoughts about the future were common in depressed patients, but were absent in 
apathetic patients who tended to show a lack of concern (Marin, 1996). This is consistent 
with similar findings suggesting that apathy is a discrete syndrome separate from 
depression (Landes et al., 2001). Because apathy is so common in ND, efforts to 
distinguish this syndrome from depression are imperative for clinicians, especially in 
guiding treatment decisions. 
Voxel-based morphometry. The study of the neuroanatomy of apathy is of 
scientific interest because its study can validate the contribution of an impairment of the 
three components of GDB to apathy in bvFTD. A large-scale neural network is thought to 
support the mechanisms (initiation, planning, and motivation) contributing to apathy by 
involving brain regions specific to each process (Levy & Dubois, 2006). By using 
neurobiological tools such as voxel brain morphometry (VBM) to study patients with 
apathy, the nature and anatomic localization of the mechanisms contributing to apathy 
can be identified. Imaging of apathetic patients, thus, allows for the dissociation of 
clinical constructs into specific processes (i.e., impairments in initiation, planning, and 
motivation) that contribute to behavior like apathy (Nader, Bechara, & van der Kooy, 
1997). From this mechanistic perspective, I hypothesized that the physiopathology of 
apathy would not be reduced to a single entity, but rather that multiple processes would 
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be shown to contribute to apathy. An investigation of each process would directly link to 
neuronal mechanisms known to underlie GDB. 
Morphometry analysis is a common tool used to measure structural differences in 
a group or across groups (Savio et al., 2011). Voxel values are modulated by Jacobian 
determinants derived from spatial normalization, which occurs after tissue classes are 
segmented (cerebrospinal fluid, grey matter, white matter). When pathology in the brain 
structures occurs, there is an impact on the fine morphology of the grey matter and 
atrophy, or tissue loss, results. White matter is also susceptible to pathological damage in 
bvFTD (Lu et al., 2013). By measuring directional changes in water diffusivity, diffusion 
tensor (DT) provides information about the microstructural tissue integrity of white 
matter tracts (Whitwell et al., 2010). 
Components of goal-directed behavior. 
Initiation component. The failure to execute behavior leads to apathy when 
processing is unable to generate a signal significant enough to initiate a response. 
Difficulty with initiation has been reported in patients with focal lesions in either the 
ACC or the basal ganglia. It is important to note that there are interconnections between 
the two regions. ACC projects to the striatum (equipped with mechanisms for behavior 
selection) and the subthalamic nucleus, both of which are input zones of the basal ganglia 
(Hikosaka & Isoda, 2010); then there is a final loop back to the ACC to form a closed 
circuit. The failure of the basal ganglia to activate the cortex or the impaired activation of 
the motor system following ACC damage can cause difficulties with initiation 
(Kotchoubey, Schneck, Lang, & Birbaumer, 2003). 
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For example, the akinetic mute state is a medical term describing patients who 
tend to sit quietly in the same position all day without speaking or talking. It has been 
specifically related to ACC damage (Mega & Cohenour, 1997). Another related term, 
abulia, describes a loss of initiative and of spontaneous thought associated with damage 
to the basal ganglia (Bhatia & Marsden, 1994). Although these symptoms are thought to 
originate from two distinct anatomic structures, they are both symptoms of a failure to 
initiate or activate GDB. 
The ACC has been well studied in dementia and neuroimaging evaluations have 
linked the ACC region to apathy in various groups. Low grey matter density in the 
cingulate gyrus was associated with increased severity measures of apathy in PD 
(Reijnders et al., 2010). Others have implicated this region in apathetic bvFTD patients 
(Massimo et al., 2009; Zamboni et al., 2008). Previous diffusion tensor imaging (DTI) 
studies investigating white matter disease and apathy have an association with the 
cingulum (Hahn et al., 2013; J. W. Kim et al., 2011; Ota, Sato, Nakata, Arima, & Uno, 
2012). Although disease in the ACC and related white matter tracts contributes to apathy 
in patients, there have been few evaluations that describe the relationship in initiation of 
GDB. 
Planning component. The ability to execute an action is highly dependent on the 
cognitive processes needed to formulate and carry out goals. Apathy related to “cognitive 
inertia” results from impairments in executive functions such as planning, working 
memory, and task switching (Levy & Dubois, 2006). These cognitive processes are 
needed to organize and structure GDB. The loss of these abilities will quantitatively 
reduce behavior. 
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Multitasking is an important aspect of executive function, referencing the ability 
to carry out several separate tasks concurrently while keeping the goals of each task in 
mind. The cognitive demand of multitasking includes selecting, organizing, and 
executing numerous tasks in a given time period (Burgess, 2000). Esposito et al. (2010) 
recently examined the aspect of multitasking related to apathy in AD patients. They 
found that an inability to perform several tasks (measured by rule breaks) was predictive 
of a lack of initiative (motivation). This outcome suggests that when patients are faced 
with complex problems that are cognitively demanding, they may become overwhelmed 
and, thus, less likely to engage in activities. An alternative hypothesis, in contrast to the 
findings of Espositio and colleagues, may be that patients perform more poorly because 
of other processes like impaired judgment or poor working-memory performance. 
Although there seems to be a relationship between apathy and deficits in multitasking, 
further studies are needed to determine the exact role of planning in apathy. 
Weintraub and colleagues (2005) examined the dimension of executive function 
as it relates to apathy in PD patients. They found that poor planning, measured by 
standardized tests of planning, was associated with increased severity of apathy. An 
important issue that was not addressed by Weintraub et al., however, is the relative 
complexity of the plan needed to engage in GDB. Consideration should be given to the 
total complexity of a task and the amount of executive resources it demands as it relates 
to apathy severity. 
The anatomic basis of executive dysfunction has been linked to dorsolateral 
portions of prefrontal cortex (dlPFC; Miller & Cohen, 2001). This region has been shown 
to play a critical role in planning and working memory. Several investigations have 
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demonstrated that working memory is associated with dlPFC (Champod & Petrides, 
2007; Funahashi, 2001; Yun, Krystal, & Mathalon, 2010). Garavan, Ross, Li, and Stein 
(2000) evaluated the role of working memory by manipulating allocation of attentional 
resources in working memory tasks. This technique was used to disentangle working 
memory from other executive processes, allowing for a pure analysis of working memory. 
Using functional MRI (fMRI) technique, they found that working memory-demanding 
tasks activated dlPFC in healthy controls. 
 Other work also suggested the importance of dlPFC for planning (Kaller, Rahm, 
Spreer, Weiller, & Unterrainer, 2011). The planning process can be assessed with 
measures like the Tower of London task where participants are asked to preplan mentally 
a sequence of moves to match a set goal. Event-related fMRI techniques are employed to 
capture planning demands in NC. Using this technique, several studies have 
demonstrated the activation of dlPFC in planning tasks (Newman, Carpenter, Varma, & 
Just, 2003; Rowe, Owen, Johnsrude, & Passingham, 2001; Unterrainer, Rahm, Kaller, 
Leonhart, et al., 2004). 
Studies suggested an association between apathy and poor executive function in 
bvFTD (Zamboni et al., 2008). Imaging studies of patients with ND have linked apathy to 
tissue loss in dlPFC and related white matter tracts including the superior longitudinal 
fasciculus (Cacciari et al., 2010; Massimo et al., 2009; Zamboni et al., 2008). Patients 
who suffered from dysfunction in these circuits failed to elaborate, manipulate, and 
integrate important information needed for behavior that was goal-directed. 
Motivation component. Finally, apathy may result from a lack of responsiveness 
to either reward or negative-consequence feedback, thereby making goal selection 
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difficult (Levy & Dubois, 2006; Rosen et al., 2002). Because rewards and avoidance of 
negative consequences constitute basic goals of behavior, motivational functions are 
based partly on the processing of reward information (Schultz, Tremblay, & Hollerman, 
2000). 
Evidence from healthy-subject MRI studies suggested that the OFC is important 
to determine information regarding interpretation of reward (Hare, Camerer, Knoepfle, & 
Rangel, 2010; Kable & Glimcher, 2007). In an fMRI study of reward processing in 
healthy controls, Smith and colleagues (2010) found that the ventromedial prefrontal 
cortex (vmPFC) is highly specialized in the way it processes rewards. In particular, they 
found that, in vmPFC, the anterior portion experienced value for social and monetary 
rewards, whereas the posterior vmPFC tracked the decision value between these two 
reward categories. Together, these findings suggest that multiple value signals exist 
simultaneously in the anterior and posterior vmPFC, each playing a distinct role in 
reward processing. 
This region also may mediate the inhibition of inappropriate responses while 
facilitating appropriate responses for goal completion (Gill, Castaneda, & Janak, 2010). 
This is important to apathy because the inability to suppress the response evoked by a 
stimulus in the immediate environment prevents a patient from selecting an appropriate 
action plan. Thus, the behavior is controlled by the emotional impact of the stimulus at 
hand. Bechara, Damasio, and Damasio (2000) tested this hypothesis in patients with 
lesions of vmPFC. Patients participated in a gambling task. Compared to controls, 
patients with vmPFC lesions preferred decks with a high immediate reward, even though 
the decks with smaller reward were advantageous in the long term. They also preferred 
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decks with low immediate punishment to those with higher immediate punishment, 
although the higher immediate punishment was more advantageous in the long run. Their 
results reinforced the notion that decisions made by patients with vmPFC lesions are 
largely based on the immediate prospects and do not consider the severity of future 
adverse consequences (Bechara et al., 2000). 
Persons with bvFTD have been examined extensively in reward processing 
because they have an early degeneration of the associated frontal circuit in comparison to 
other neurodegenerative conditions (Rabinovici et al., 2007). Grossman and colleagues 
(2010) examined the interpretation of positive and negative situations in bvFTD. They 
found bvFTD participants were particularly impaired in interpreting negative 
consequences of a social situation (e.g., “Rolling through a red light at 2am when there is 
a police car at the intersection”). Their insensitivity to negative consequences may 
underlie reduced motivation. 
The study of reward processing and resultant apathetic behavior in the bvFTD 
population offers essential insights into the functions of the OFC. Experimental evidence 
using imaging techniques in patients with bvFTD has emphasized the link between 
orbitofrontal regions and apathetic behaviors. Comparison of brain activity between 
apathetic and nonapathetic bvFTD participants using positron emission tomography 
(PET) data revealed patients have decreased activity in the OFC of apathetic participants 
(Peters et al., 2006). Rosen and colleagues (2005) examined apathy, measured by the 
Neuropsychiatric Inventory (NPI), and found apathy scores to be independently 
associated with atrophy in the ventromedial frontal gyrus. The uncinate (UNC) is a major 
tract connecting the anterior temporal lobe with the medial and lateral prefrontal cortex 
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(Papagno et al., 2011), areas known to be important for GDB (Kable & Glimcher, 2007). 
DTI studies performed in patients with AD and progressive supranuclear palsy (PSP) 
implicated UNC in apathy (Hahn et al., 2013; Kvickstrom et al., 2011). The conclusions 
from these imaging studies suggested that the OFC and related white matter tracts have a 
relationship to apathy, although distinct areas of this region may have specific roles. 
Summary of Key Points 
Apathy can be viewed as the quantitative reduction of GDB and is a common 
behavior in neurodegenerative conditions, especially bvFTD. Studies of the frontal-
subcortical circuits contributed to explaining its phenomenological presentation. In 
support of this view, and using the above definition, I hypothesized that three impaired 
GDB mechanisms (initiation, planning, and motivation) contribute to subtypes of apathy. 
The first subtype of apathy is related to an initiation difficulty. This subtype of apathy can 
be seen in patients with disease in the ACC. The second subtype is due to impaired 
planning, which results from disease in the dlPFC. The third subtype of apathy is related 
to related to impaired goal selection and motivation that occurs when disease affects 
areas in the OFC. 
Research Design and Methods 
Overview of research design. In Aim 1, structural MRIs in bvFTD participants 
were compared to NC, and regression analyses related apathy scores (see Table 1) to grey 
matter structures and associated white matter tracts. In Aim 2, results on a computerized 
task, the PACT, were analyzed for apathy subtypes in bvFTD using the PACT measures, 
and regional grey matter volume was then assessed for each impaired GDB component. 
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In Aim 3, findings from Aims 1 and 2 were used to support the development of a research 
proposal to examine mechanisms of longitudinal decline and neural compensation. 
Table 1 
Sample Criteria 
Inclusion Exclusion 
Diagnosis of bvFTD (Rascovsky et al., 2011) or 
NC. 
Other neurologic conditions such as stroke or 
hydrocephalus, primary psychiatric disorder such as 
depression or psychosis, or systemic illness that 
could interfere with cognitive functioning. 
Mild disease stage (measured by Mini-Mental 
State Exam ≥ 20). 
Mini-Mental State Exam ≤ 19 to minimize 
confounding factors related to cognitive impairment 
by excluding persons with moderate or severe 
dementia.  
No depression as determined by Geriatric 
Depression Scale Short Form score of ≤5.  
Depressed patients (Geriatric Depression Scale-
Short form score >5) since apathy is often clinically 
confused with depression and could confound 
interpretation of the data. 
Modest doses of SSRI or antipsychotic medication 
may have been needed for treatment as clinically 
indicated, and, thus, were allowed. A stable dose 
(no change in 3 months) was necessary to 
minimize potential confound because these 
medications can contribute to apathy (Benoit et 
al., 2008). 
Patients taking regular doses of benzodiazepines and 
other soporific medications because of the sedating 
effects of these drugs.  
A reliable caregiver who had frequent contact with 
the patient (>3 times/week for ≥1 hour).  
Patients who do not have caregiver contact to ensure 
accurate proxy ratings of the patient’s behavior, 
since patients with bvFTD typically have poor 
insight into their deficits (Eslinger et al., 2005). 
Neuropsychiatric Inventory apathy subscale 
frequency by severity score ≥1. 
Captures bvFTD patients with higher likelihood of 
having apathy syndrome. 
Ability to speak and understand English language 
sufficient to complete the questionnaires. 
Patients with English language skills insufficient to 
complete questionnaires. 
 
Participants and setting. Participants with bvFTD and age- and education-
matched NC who were enrolled in the ongoing longitudinal study, “Cognitive and Neural 
Impairment in Frontotemporal Dementia” (P01-AG17586) at the University of 
Pennsylvania were selected for the proposed research. These participants had available 
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neuropsychological, neuroimaging, and biomarker data. I focused particularly on bvFTD 
because apathy is very common in this condition, these patients do not have physical 
limitations that can confound the quantitative assessment of reduced GDB, and there are 
no language or visuospatial deficits that can potentially limit the interpretation of bvFTD 
patient performance. Participation was limited to those with apathy, determined by scores 
on the NPI to increase the likelihood of capturing the phenomenon of interest. 
Power Analysis. To conservatively estimate the power required to detect a 
significant difference on the PACT between NC and bvFTD participants, I used the 
PACT measure with the smallest difference between controls and bvFTD participants 
found in our pilot data (Initiation score: bvFTD = 522ms ± 224.17 vs. NC = 375ms ± 
69.46). With reasonable assumptions of 1.0 SD difference in performance between 
groups and a beta of 0.8, a power analysis suggested that 18 participants were required in 
each group to achieve a difference that is significant at the .05 level using Wilcoxon rank-
sum test. For the VBM imaging study, a minimum of 20 participants were required in 
each group to detect a 1mm (equivalent to 1 voxel) change in grey matter at the p < .05 
(corrected) level with a beta of 0.15 (power =. 85; Lerch & Evans, 2005; see Table 2). 
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Table 2 
Power Analysis 
SD diff β = 0.8 β = 0.9 
0.5 68 91 
0.75 31 41 
1.0 18 24 
1.5 9 12 
2.0 6 8 
Note. *Sample size needed to detect a mean difference between two groups from Wilcoxon rank-sum test; 
alpha = .05. 
Procedures. As previously described, this dissertation study was part of a larger, 
ongoing longitudinal study entitled “Cognitive and Neural Impairment in Frontotemporal 
Dementia” (P01-AG17586; PI: Virginia Lee, PhD, Clinical Core Leader: Murray 
Grossman, MD). This study included individuals from the parent study who were 
diagnosed with bvFTD and NC. University of Pennsylvania Institutional Review Board 
(IRB) approval was initially obtained for P01-AG17586 in January 1999 and the most 
recent continuing review approval from the IRB in September 2013 encompassed the 
MRI procedures and the battery of neuropsychological testing that included the PACT. 
I met with Dr. Grossman on a weekly basis to determine whether any newly 
eligible patients had been entered into the abovementioned study. If so, the neurologist or 
clinical coordinator asked the patient and caregiver if they were interested in hearing 
more about the dissertation study. If so, I met the patient and caregiver to give an 
overview and confirm their intention to participate. 
Ideally, I would collect the PACT data, neuropsychological data and MRI data on 
the same day. To maximize recruitment, retention, and convenience to participants, the 
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patients and caregivers had the option to request that PACT and neuropsychological data 
be collected during a follow-up in-home visit. In any case, I collected the MRI and PACT 
data in the same 6-month period. Given the rate of brain volume change in bvFTD, 6 
months is a widely accepted time frame in neuroscience research (Whitwell et al., 2008). 
Data collection. I obtained the data for this study, including that generated from 
the PACT, neuroimaging, and neuropsychological tests, from each participant in the 
ongoing study (P01-AG17586). I administered the PACT which took approximately 45 
minutes to complete. The neuroimaging sequence, completed by Department of 
Radiology technicians, generally took 30 minutes to complete. The neuropsychological 
tests were conducted by trained research technicians and took approximately 60 minutes 
to complete. 
I collected data in the Cognitive Neurology Clinic and in the Department of 
Radiology at the Hospital of the University of Pennsylvania. I conducted the PACT and 
neuropsychological tests in a quiet room in the Department of Neurology. Alternatively, 
if the patient and caregiver desired, I collected the PACT and neuropsychological testing 
during an in-home visit. 
Instrumentation. 
The Philadelphia Apathy Computerized Test (PACT). Experimental computer 
tests examining the basis for a social behavior are useful in studying the mechanisms 
contributing to the behavior. Moreover, they are quantitatively rigorous. The PACT was 
intended to measure three components of GDB—initiation, planning, and motivation. 
The PACT was developed based on a review of experimental paradigms in the scientific 
literature and clinical observations (Elliott, Agnew, & Deakin, 2010; Jenkins, Jahanshahi, 
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Jueptner, Passingham, & Brooks, 2000; Ruh, Cooper, & Mareschal, 2010). In all 
experimental conditions, a trial began when the participant depressed a computer “start” 
key with one finger. Reaction time (RT) to lift this finger from the start key in response to 
a signal (RT1) and then RT to depress the target key once lifted from the start key (RT2) 
were each measured. A practice block, in which participants received instructions about 
task performance and 12 practice trials, preceded each of three experimental conditions 
described below. 
Initiation refers to one’s ability to self-generate or activate actions (Levy & 
Dubois, 2006). In the simplest condition designed to measure initiation, the participant 
began a trial by depressing the start key; a central stimulus appeared on the computer 
screen, and a fixed central target key was then depressed in response to this stimulus; 
over 48 trials, the signal occurred on average 1,250msec (range 500–5000msec) after 
depressing the start key. Initiation was assessed by RT1 in this condition. 
Planning refers to the ability to elaborate plans of action (Levy & Dubois, 2006). 
Thus, assessing the planning component required a resource-demanding task that 
depended on the integration of strategies to meet the challenges of the condition (Sorel & 
Pennequin, 2008; Toglia & Berg, 2013). In the second condition, designed to assess the 
planning component of GDB, two levels of task difficulty were assessed. In the first level 
(simple planning), after depressing the start key, participants were signaled by randomly 
ordered lateralized visual stimuli to press a left or right target key (stimulus appears on 
left, then go left; stimulus appears on right, then go right). In the second, more complex 
level, one of two lateralized keys is pressed contingent on the combination of patterns in 
a central visual stimulus (if the stimulus is blue or has horizontal stripes, the key on the 
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left is correct; if the stimulus is orange or contains vertical stripes, the key on the right is 
correct). To assure that planning could be assessed specifically, we minimized the 
influence of working memory confounds by making the patterns visually available to 
participants during performance. We assessed two measures of planning: total latency in 
the complex planning condition and the difference in response times between the two 
levels of difficulty. 
Motivation refers to the ability to associate affective signals (positive or negative) 
with value in order to perform actions (Levy & Dubois, 2006). In the third condition, 
designed to assess motivation, the simple condition was repeated with an explicit 
monetary incentive using a point system (monetary units) to reward participants for 
responding correctly and more rapidly. Participants received feedback on the computer 
screen about their response speed after each trial. Sensitivity to negative consequence 
was assessed by having a “penalty” condition. In this “penalty” condition, we gave 
participants a number of monetary units at the beginning of each task, and took away 
monetary units if they did not respond correctly and more rapidly. I used the penalty 
condition measure to assess motivation because previous work has shown that bvFTD 
patients are particularly insensitive to negative feedback (Grossman et al., 2010). I used a 
point system involving “monetary units” and monetary units were “converted” to actual 
money in a manner that allowed all participants to receive the same total payment at the 
end of the study. 
I obtained 48 experimental trials during each condition. I measured RT1, RT2, 
total latency (RT1 + RT2) and errors. Average RTs for initiation, planning, and 
27 
	  
motivation (see Table 3) were each generated from the conditions described above and 
used in the regression analyses (Aim 1). 
Table 3 
Scores Generated From the PACT 
Score Measure 
Initiation score Average Reaction Time 1 in simple condition 
Planning score Average total latency in complex planning condition 
Motivation score Average total latency in simple penalty condition 
 
Structural MRI. I obtained MRI data with the support of P01-AG17586 (PI: 
Virginia Lee, PhD; Clinical Core Leader: Murray Grossman, MD). Three-dimensional 
T1-weighted structural MRI provided 1 mm3 resolution for assessing grey matter-volume 
loss, and we used spoiled gradient-echo imaging (MPRAGE on our Siemens Trio) with 
an inversion preparation to increase grey/white matter contrast at high field. We used 
three dimensional spoiled gradient echo imaging parameters as follows: TR = 1620ms, 
TI = 950ms, TE = 3ms, flip angle = 15°, 160 contiguous slices 1.0 mm thick, in-plane 
resolution 0.9×0.9 mm, FOV = 192x256mm2, matrix = 192 X 256, 1NEX with a total 
scan time of 6 min for the entire volume. We repeated this sequence twice, allowing 
signal-to-noise ratio to be increased by signal averaging following realignment, or one 
volume could be discarded if excessive motion (> 3mm in any axis) occurred. We 
acquired diffusion-weighted images (DWI) using a single-shot, spin-echo, diffusion-
weighted echo planar imaging sequence (FOV = 245mm; matrix size = 128 × 128; 
number of slices = 57; voxel size = 2.2mm isotropic; TR = 6,700ms; TE = 85ms; fat 
saturation). In total, we acquired 31 volumes along 30 noncollinear directions per subject, 
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one without diffusion weighting (b = 0 s/mm2) and 30 with diffusion weighting 
(b = 1,000 s/mm2). 
Neuropsychological tests. Researchers collected neuropsychological data shown 
in Table 4 for the parent study and made them available to me. Researchers use 
neuropsychology test results to help to improve characterization of apathy in bvFTD, 
because preliminary data associate apathy with executive and social deficits (Chow et al., 
2009; Eslinger et al., 2011; Eslinger et al., 2012; Eslinger et al., 2007; Girardi, 
Macpherson, & Abrahams, 2011). The overall guiding principle for the parent study was 
that the neuropsychological battery was comprehensive in its scope, and included 
measures with good psychometric properties that were well normed for a broad age range, 
yet administrable in a reasonable amount of time (in our experience, about 60 minutes). I 
used two of the available measures to execute the inclusion/exclusion criteria, and, 
although no measures specific to components of GDB (initiation, planning, and 
motivation) were included in the database, several tests or items sampled some aspects of 
these components, thereby potentially providing auxiliary support for the PACT. 
Data management. I managed data using web-based, intranet data management. 
The database server was Microsoft SQL Server 2005 with front end application 
developed in PHP dynamic web language, hosted via Microsoft IIS 6.0 web server. The 
database, located on the University of Pennsylvania Health System (UPHS) network, was 
protected from the Internet via the UPHSnet firewall. The servers were part of the UPHS 
enterprise backup system. Backups were performed daily by the UPHS backup 
administrators. MRI data were archived onto compact disk (CD) from the scanner 
immediately following data acquisition. Data were loaded onto a workstation, stripped of 
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identifying information, and transferred via secure ftp to a specific account for this 
project on the Center for Functional Neuroimaging (CfN) web server at the University of 
Pennsylvania. Data stored on the CfN cluster were backed up weekly using SDLT tape, 
and daily interim backups were performed onto external firewire hard drives. All data 
entered were cleaned, transformed and analyzed using the statistical software package 
SPSS 21.0 for Mac. 
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Table 4 
Neuropsychological Data 
Name of test Time Brief description Use in study 
Mini-Mental State 
Exam (Folstein, 
Folstein, & 
McHugh, 1975) 
10 minutes A screen for dementia. Determines cognitive 
impairment using a cutoff of 23. The instrument has a 
sensitivity of 82% and specificity of 99% for 
determining cognitive impairment with this cutoff 
(Tangalos et al., 1996). 
Mini-Mental State 
Exam assessed 
severity of cognitive 
dysfunction to 
determine 
inclusion/exclusion. 
Geriatric 
Depression Scale 
Short Form (Sheikh 
& Yesavage, 1980) 
10 minutes Measures depression briefly in elderly and in persons 
with dementia where a longer form may be burdensome 
(Burke, Roccaforte, & Wengel, 1991; Lach, Chang, & 
Edwards, 2010). This instrument has sensitivity and 
specificity of 87% and 83% respectively. The Geriatric 
Depression Scale was chosen because it ascertains 
affective symptom ratings of depression. 
Identified depressed 
patients who were 
then excluded from 
the study. 
Neuropsychiatric 
Inventory 
(Cummings, 1994)  
15 minutes Evaluates 12 neuropsychiatric disturbances, including 
apathy, as rated by caregivers, each with a frequency by 
severity score. Content validity, concurrent validity, 
interrater reliability and test–retest reliability of the 
Neuropsychiatric Inventory were established by past 
work (Cummings et al.,1994). 
Confirmed caregiver-
perceived presence of 
apathy for inclusion in 
the study, and 
measured associated 
caregiver distress. 
Apathy Evaluation 
Scale-Informant 
Rated (AES-I) 
(Marin, Biedrzycki, 
& Firinciogullari, 
1991)  
10 minutes An 18-item caregiver-completed scale that is 
commonly used to quantify global apathy. Responses to 
items were recorded on a 4-point Likert-type scale with 
the following categories: Not at All True, Slightly True, 
Somewhat True, and Very True. A higher score 
represents greater apathy severity. 
Response to the single item, “He/she has motivation,” 
was used to determine the subject’s level of motivation. 
Assessed caregivers’ 
perceptions of the 
patient’s level of 
motivation. 
Digit Span 
Backward  
3 minutes Digits are repeated in the reverse. Assesses mental 
manipulation and planning. 
Assessed planning. 
Trail Making  5 minutes An alternating pattern is traced between numbers and 
letters. 
Assessed planning. 
Letter Guided 
Fluency  
5 minutes Name words beginning with the letters F, A, and S in 
60 seconds each; first quartile fluency assesses 
initiation (Lamar, Zonderman, & Resnick, 2002). 
Assessed planning, 
initiation. 
Overall plan for analysis. I described the overall sample demographically and 
according to continuous measures of the PACT and relevant scores on the 
neuropsychiatric measures using means, standard deviations, and interquartile ranges. For 
categorical data, I used frequencies and percentages. 
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Analysis Aim 1. 
Grey matter imaging. I used VBM to quantify significant grey matter changes in 
the bvFTD sample acquired with high resolution volumetric T1 MPRAGE images. All 
images were preprocessed using PipeDream (Sourceforge, 2014) and advanced 
normalization tools (ANTS, Penn Image Computing Science Lab, 2014) to perform the 
most stable and reliable multivariate normalization and structure-specific processing 
currently available (Avants, Epstein, Grossman, & Gee, 2008). PipeDream deforms each 
individual dataset into a standard local template space in a canonical stereotactic 
coordinate system. Core processing involved mapping T1 structural MRI to a population-
specific template consisting of an unbiased average-shape and average-appearance image 
derived from a representative population of 25 healthy seniors and 25 patients with FTD 
(J. Kim et al., 2008). This procedure provided superior representations of variable 
anatomy as occurs in distinct populations such as in the examination of a healthy 
population and those with a neurodegenerative condition (Avants & Gee, 2004). I used a 
diffeomorphic deformation for registration that is symmetric so that it is not biased 
toward the reference space (for computing the mappings) and preserves topology to 
capture the large deformation necessary to aggregate images in a common space. These 
algorithms allowed template-based priors to guide cortical segmentation and compute 
grey matter atrophy (Das, Avants, Grossman, & Gee, 2009). We used SPM8 to smooth 
images using a 4mmFWHM Gaussian kernel and to compare patients to matched controls 
using a two-sample t-test. We accepted clusters containing a peak voxel that survived a 
p < .001 (FDR-corrected) height threshold and a 50 adjacent-voxel extent. We then used 
the regression module in SPM8 to identify the relationship between performance on each 
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PACT score (see Table 3) and grey matter density. To constrain the interpretation of the 
regression analysis to areas of known disease in participants, we used an atrophy mask 
generated from the t-test contrasts of bvFTD relative to NC. For each regression, we 
entered a single PACT score (average RTs over 48 trials) for each condition (see Table 3) 
for each patient. For the regression analyses, we accepted that a cluster was related to 
behavior if it contained a peak voxel which survived a p < .005 height threshold and a 30 
adjacent-voxel extent. 
White matter imaging.  DWIs were preprocessed with PipeDream and ANTS, as 
above. We removed motion and distortion artifacts by affine coregistration of each DWI 
to the unweighted (b = 0) image. We computed DTs using a linear least squares algorithm 
(Salvador, Suckling, Schwarzbauer, & Bullmore, 2005) implemented in Camino (Cook et 
al., 2006), and tensors were reoriented using the preservation of principal directions 
algorithm (D. C. Alexander, Pierpaoli, Basser, & Gee, 2001). We computed fractional 
anisotropy (FA) from the DT image for each subject and corrected distortion between T1 
and DT images by registering the FA image to the T1 image. We warped each 
participant’s T1 image to the template via the symmetric diffeomorphic procedure in 
ANTS; then warped the FA image to template space by applying the T1-to-template 
warps. 
We smoothed FA images using a 4mm full width at half maximum (FWHM) 
isotropic Gaussian kernel. I performed DTI analyses of FA in SPM8 using the two-
samples t-test module and analyzed DTI volumes using an explicit mask (FA ≥ 0.25) to 
constrain comparisons to regions of white matter. Comparisons of bvFTD participants to 
matched controls used a p < .005 (false discovery rate [FDR]-corrected) height threshold 
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and a 200-voxel extent. I constrained regression analyses to white matter tracts with 
reduced FA using an explicit mask generated from the results of the direct comparison 
with NC. Using a deterministic tractography procedure in Camino (Cook et al., 2006), I 
tracked white matter fibers in a healthy-subject template generated using the DTI 
sequence described above. I retained fiber tracts that passed through voxels of reduced 
FA to define the mask for regression analyses. I accepted a significant cluster with a 
volume of 150 adjacent voxels and a peak voxel Z-score > 3.3 (equivalent to p < .0005). 
Analysis Aim 2. 
Behavioral data. I described the sample according to the proposed apathetic 
subtype of initiation, planning, and motivation (see Table 5) using means, standard 
deviations, and z-scores. Shapiro–Wilks tests were used to assess normality in the data. I 
examined differences on scores on each task (initiation score, planning score, and 
motivation score) between bvFTD and NC groups using independent samples t-tests. 
Because the data were not normally distributed, I assessed differences between subject 
groups using nonparametric tests such as the Mann–Whitney U statistic. I calculated 
correlations with neuropsychiatric tests (see Table 4) using Spearman’s rho. I expected 
initiation measures to be significantly associated with first quartile letter-guided fluency. 
I expected planning measures would be significantly associated with performance in the 
overall score on the digit span backward, trail making, and letter-guided fluency. Last, I 
expected a significant association between motivation measures and score (1–4) on the 
single AES-I item, “He/she has motivation.” 
I hypothesized specific apathy profiles as well, and described the number of 
participants in each subtype according to predetermined criteria (see Table 5). I generated 
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individual z-scores relative to NC. I designated participants as a specific subtype if the z-
score was ≥ 2.0 for one profile criteria, but within the range of normal (i.e., z-score ≤ 2.0, 
p ≤ .05) for the remainder of the tasks. 
Table 5 
Behavioral Criteria for Apathy Subtypes 
Subtype profile Criteria 
Initiation Significantly slow Reaction Time 1 in simple condition 
Does not have slowed latencies for complex condition 
Able to improve performance on the simple condition in response to penalty 
Planning Significantly slowed on complex planning condition and, for those with multiple 
impairments, significant slowing on the complex planning condition compared to the 
simpler planning condition 
Does not have slowed initiation for simple condition 
Able to improve performance on the simpler planning condition in response to penalty 
Motivation Significantly slowed on simple penalty condition and fails to improve performance 
with penalizing motivators 
Does not have slowed initiation for simple condition 
Does not have slowed latencies for complex condition 
 
Grey matter imaging. I obtained a priori defined regions of interest (ROI) for 
ACC, dlPFC, and OFC. I selected these ROIs based on literature suggesting that poor 
initiation is related to disease in ACC (Kotchoubey et al., 2003; Reijnders et al., 2010), 
poor executive function is related to disease in dlPFC (Kaller et al., 2011; Unterrainer, 
Rahm, Kaller, Leonhart, et al., 2004; van den Heuvel et al., 2005) and reduced motivation 
is related to disease in OFC (Diekhof, Falkai, & Gruber, 2011; Sescousse, Redoute, & 
Dreher, 2010). I used the standardized automated anatomical labeling (AAL) and 
parcellation method (Tzourio-Mazoyer et al., 2002) to label the following ROIs. The first 
ROI (e.g., initiation) was centered on the ACC (AAL label = ACIN). The second (e.g., 
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planning) ROI was centered on the middle frontal gyrus portion of the dlPFC (AAL label 
= F2). The last ROI (e.g., motivation) was composed of the orbital regions of the middle 
and superior frontal gyri (AAL labels = F10, F20). Additionally, I assigned a control ROI 
in the midtemporal (MT) region (AAL label = T2). I chose this region because it is an 
area implicated in bvFTD (Brettschneider et al., 2014), but is not hypothesized to 
contribute to GDB. For all ROIs, I computed the mean grey matter probability (GMP) 
value, divided by the subject’s individual average whole-brain GMP value. I used this 
ratio to examine relative differences in regional composition of grey matter in frontal 
areas thought to underlie GDB impairments and the control region in the lateral temporal 
lobe. 
Anticipated Study Difficulties and Alternative Approaches Used to Achieve 
Aims. 
Prior to initiating this study, I anticipated potential difficulties and identified 
alternative approaches to achieve the aims: 
Interpretation and potential problems, Aim 1. I predicted that apathetic bvFTD 
participants would have significant atrophy in the frontal lobe. Further, PACT initiation 
scores would be related to significant ACC atrophy and associated white matter tracts; 
PACT planning scores would be related to atrophy in dlPFC and associated white matter 
tracts, and PACT motivation scores would be related to atrophy in OFC and associated 
white matter tracts. These predictions were made based on the literature suggesting that 
poor initiation is related to ACC disease (Kotchoubey et al., 2003; Reijnders et al., 2010), 
poor executive function is related to disease in dlPFC (Kaller et al., 2011; Unterrainer, 
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Rahm, Kaller, Ruff, et al., 2004), and reduced motivation is related to disease in OFC 
(Diekhof et al., 2011; Sescousse et al., 2010). 
Anticipating that the regression analyses might not detect a distinct relationship 
between grey matter density and behavioral performance, I planned to use cortical 
thinning rather than grey matter density. It was possible I would find atrophy related to 
the striatum, given the observation of apathy in Parkinson’s patients with striatal disease 
(Drapier et al., 2006), strong frontal-striatal connections (Bonelli & Cummings, 2007) 
and the observation of histopathological disease in the striatum of bvFTD (Seelaar, 
Rohrer, Pijnenburg, Fox, & van Swieten, 2011; Whitwell et al., 2009). Anticipating the 
possibility that participants with long disease duration would have diffuse, nonspecific 
atrophy, I examined only participants with mild cognitive impairment. I expected some 
difficulty obtaining imaging in some participants because of time restriction, medical 
contraindication (e.g., claustrophobia or pacemakers) and participant preferences. If that 
were the case, I still planned to ask subjects to participate in the PACT assessment, using 
t-tests to confirm no significant differences between those with and without imaging data. 
Interpretation and potential problems, Aim 2. I expected differences in PACT 
scores between bvFTD and NC groups. I predicted each apathetic subtype would show a 
distinct performance profile on the PACT. The initiation subtype would have slow RT1 
across all conditions in the PACT. Once initiated, tasks would be performed slowly 
(RT2) but accurately. Participants would not have slowed latencies for complex 
conditions and would be able to improve their total latency times in response to 
incentives. The planning subtype would have significantly slow total latency on the 
complex planning condition, but participants would not have significantly slowed 
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initiation. They would also improve their time in response to incentive. The motivational 
subtype would improve less in response (measured by total latency) to financial 
incentive—and particularly the penalty condition—than the initiation and planning 
patients under the simpler planning condition, but would not have slowed initiation times, 
and would not have disproportionally slowed performance for the complex planning 
condition. This insensitivity to penalty is supported by previous studies that show bvFTD 
patients are insensitive to negative consequences but respond to a reward (Farag et al., 
2010; Grossman et al., 2010; Torralva, Roca, Gleichgerrcht, Bekinschtein, & Manes, 
2009). 
I acknowledged that my data might not support clear distinctions between the 
apathy subtypes; in this case, I planned to adjust my subtype criteria, which might include 
more stringent inclusion criteria for one or more of the subtypes. 
Human subjects. 
Human subjects involvement and characteristics. This dissertation study was 
part of a larger ongoing longitudinal study entitled “Cognitive and Neural Impairment in 
Frontotemporal Dementia” (P01-AG17586; PI: Virginia Lee, PhD, Clinical Core Leader: 
Murray Grossman, MD). For the purpose of this study, we offered participation to 
subjects diagnosed with bvFTD and NC. See Table 1 for a description of inclusion and 
exclusion criteria. I selected a total sample of 37 subjects (20 bvFTD and 17 NC). 
Primary study approval. University of Pennsylvania IRB approval was initially 
obtained for P01-AG17586 in January 1999 from the University of Pennsylvania. Most 
recently (September 2013), the University of Pennsylvania IRB awarded the P01 
continuing approval for a protocol that included neuropsychological testing including the 
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PACT, questionnaires, and MRI procedures. For the dissertation study, I obtained IRB 
approval to amend the parent study (P01-AG17586) to include the above analyses on July 
25, 2012. 
Source of materials. I obtained the materials for this study, including data 
generated from the PACT, neuroimaging, and neuropsychological tests (including the 
NPI), from participants in the parent study. The PACT took approximately 45 minutes to 
complete. The neuroimaging sequence generally took 30 minutes to complete. The 
neuropsychological tests took approximately 60 minutes to complete. 
I collected data in the Cognitive Neurology Clinic and in the Department of 
Radiology at the Hospital of the University of Pennsylvania. If the subject and caregiver 
desired, I collected the PACT and neuropsychological testing during an in-home visit. I 
entered the raw data, which included subject and caregiver demographics, directly into a 
Web-based data-management system. I anonymized data through the use of alpha 
numeric identification numbers, and kept the key for the identification in a separate 
password-protected site. The server was log-in accessible only to the investigators and 
key study personnel. Data and all analyses for this study were kept on this server. After 
the data were entered, I stored the raw data in the Department of Neurology in a secured 
file cabinet and will keep it for 6 years to satisfy university policy. 
I archived all MRI data from the scanner onto compact disk immediately 
following data acquisition. I loaded data onto a workstation, stripped them of identifying 
information, and transferred them via secure ftp to a specific account for this project on 
the CfN web server at the University of Pennsylvania. I backed up data stored on the CfN 
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cluster weekly using SDLT tape, and made daily interim backups onto external firewire 
hard drives. 
Potential risks and adequacy of protection against risks. 
Informed consent and assent. Informed consent and assent for the parent study 
were obtained from the caregiver and patient in accordance with the University of 
Pennsylvania IRB approved procedures. Participants were recruited from a pool of 
patients and their caregivers in the Cognitive Neurology Clinic at the Hospital of the 
University of Pennsylvania. After participants were evaluated for inclusion/exclusion by 
a cognitive neurologist (MG), they were provided a written and verbal explanation of the 
purpose, protocol, risks, and benefits of the study. At all times during the informed-
consent process, potential study participants were reminded that participation was 
voluntary and withdrawal was an acceptable alternative to participation. After 
participants/caregivers had an opportunity to ask questions, fully informed written/assent 
was obtained from patient and caregiver. 
Assessing each individual’s capacity was an important step in the informed-
consent process, because cognitively impaired individuals, such as those with bvFTD, 
may not have been able to understand relevant information or may not have been able to 
reason about the alternatives available to them. Previous research has shown that ND 
patients with preserved awareness of their diagnosis, symptoms, and prognosis are likely 
to retain the capacity to make decisions about their care (Karlawish, 2008). Because 
judgment and insight are lost early in bvFTD patients (Piguet, Hornberger, Mioshi, & 
Hodges, 2011), we did not assume capacity to consent even with “mildly impaired” 
scores on the MMSE. To our knowledge, no studies addressed the decision-making 
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capacity of bvFTD patients. Capacity assessment remains a clinical assessment 
performed by the cognitive neurologist (MG). If patients did not have sufficient capacity 
to consent, then assent was obtained. At minimum, assent from the patient and proxy 
consent were obtained for all participants. Potential risks for patients and caregivers who 
participated in this study were related to subject burden and distress as well as 
administration of testing materials. A list of the potential risks in this study and the 
protections against risks are addressed below. 
Risk associated with PACT and/or neuropsychological testing for patients. 
Patients took no physical risks by performing the PACT and answering questions 
associated with the neuropsychological tests. Some participants may have become 
fatigued or felt anxious while performing these tests. 
Protection against risk. The testing was divided into several small sections, 
thereby providing frequent rest periods, and the testing may have continued during a 
follow-up session, as appropriate. Participants could request additional rest periods at any 
time. Prior to each task, we discussed the nature of the task. Because participation in the 
study was voluntary, participants could choose not to answer any question and had the 
right to withdraw if desired. 
Risks associated with MRI. There is little risk associated with MRI studies. Many 
participants have been safely studied in MRI research. The technique uses no radiation, 
so it can be repeated with no known adverse effects (Cogbill & Ziegelbein, 2011). The 
measurement is painless, but it is noisy inside the magnet. The magnetic field is not 
harmful in itself, but implanted devices (e.g., pacemaker) that contain metal may 
malfunction during the MRI. In addition, a metallic object may fly through the air toward 
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the magnet and hit the patient. Last, participants may experience claustrophobia in the 
machine; thus, we excluded participants with a known history of claustrophobia from the 
MRI portion of the study. 
Protection against risk. We gave participants earplugs to decrease the noise level 
while in the scanner. Because of the strong magnetic field, we excluded patients with 
pacemakers or other metallic implants from this component of the study. Participants and 
caregivers completed an MRI screening form with study personnel before entering the 
MRI room. The purpose of the form was to identify known metallic implants that would 
be a contraindication for MRI. We required participants to remove all metal from their 
person and clothing, including metal objects in their pockets before entering the MRI 
room. Last, we gave participants a call bell to squeeze if they became uncomfortable or 
claustrophobic, and the MRI study was stopped at that point. 
Risks associated with caregiver questionnaires. We held some concern for 
psychological distress for the family caregivers when we administered the NPI and AES-I. 
Neuropsychiatric features in dementia can be a sensitive topic and some caregivers were 
at risk for becoming upset. Similar research studies involving interviews with spousal 
caregivers, however, found that the experience afforded them a positive opportunity to 
share their experience and contribute to scientific knowledge (Hellstrom, Nolan, 
Nordenfelt, & Lundh, 2007; Mastwyk, Ritchie, LoGiudice, Sullivan, & Macfarlane, 
2002). 
Protection against risk. In the event that a negative emotional response occurred, 
we reminded caregivers that they did not have to answer any question with which they 
felt uncomfortable and they were provided a break. Additionally, we provided caregivers 
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with support-group information. The name and contact information for a licensed 
psychologist who has experience working with caregivers of persons with dementia was 
also available. 
Ethics of participant payment. We paid participants $35 for the burden 
associated with the MRI procedure of the parent study. Also, we paid participants an 
additional $10 for participating in the PACT. This test asked participants to make 
decisions about picture stimuli on a computer screen. The experimental hypothesis tested 
whether participants were able to improve their times in return for positive feedback. In 
the PACT, points were awarded for appropriate responses or deducted for inappropriate 
responses. We told all participants that the number of points they accumulated would be 
converted into a monetary award at the end of the experiment. We constructed a 
conversion scale so that we paid all participants $10 for their participation, regardless of 
the points they earned. To calculate reimbursement, we used the wage-payment model. 
This payment model operates on the notion that research participation requires little skill, 
but does require time and effort (Dickert & Grady, 1999). We chose this model because it 
standardizes the payment process so that all participants were paid equally. 
Potential benefits of the proposed research to human subjects and others. We 
informed participants that they would have no additional risk and receive no additional 
benefits from analysis of data in this study. It is possible that although these results may 
benefit patients and caregivers in the future, participants in this study would not realize 
an immediate or direct benefit from participating. Given the minimal risks associated 
with this study, and the general benefits to the patients and families with ND and the 
research community, the overall risk-to-benefit ratio was favorable. Further, we found 
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research studies that suggested there are altruistic benefits to participating in dementia 
research, even if the subject is not directly benefited (Law, Russ, & Connelly, 2013; 
Lynoe, Sandlund, & Jacobsson, 1998). 
Importance of knowledge to be gained. The overall goal of this innovative 
research project was to identify the neural mechanisms that contribute to apathy in 
patients with a certain type of ND. By identifying three distinct impairments in GDB, 
interventions can be explored based on an individual’s pathology profile. Interventions 
may help the apathetic patient engage in activity, but the interventions must be tailored to 
the subtype of apathy. To facilitate this research, researchers need an objective evaluation 
that is able to differentiate subtypes of apathy by neuroanatomical mechanisms. Then a 
systematic evaluation of existing interventions for apathy will be warranted, followed by 
the testing of interventions designed by apathetic subtype. These studies are necessary to 
improve patient and caregiver quality of life. 
Inclusion of women and minorities. The sample included both male and female 
adults. FTD affects slightly more men than women (Johnson et al., 2005), and to date, the 
parent study tended to recruit slightly more male than female patients. In the case of an 
imbalanced enrollment, I planned to query the database to find a representative sample. 
Recruitment, selection, and enrollment were not discriminatory regarding race or 
gender; however, an unequal number of minorities were enrolled in the parent study. 
Recent research suggested that members of minority populations are less likely to 
participate in dementia research because, relative to their Caucasian counterparts, they 
are often diagnosed later, and thus do not receive specialized dementia care (Cooper, 
Tandy, Balamurali, & Livingston, 2010). Ongoing efforts to engage a community of 
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minorities included a monthly educational series at community centers in Philadelphia 
and surrounding areas. Researchers used these efforts to aggressively increase and retain 
minority-group representation. 
Inclusion of children. The participants in this study were adults age 21 and older. 
We excluded children, as this research relates to adults with ND. 
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Abstract 
Apathy, the major manifestation of impaired GDB, is the most common neuropsychiatric 
syndrome associated with bvFTD. The behavioral and biological mechanisms of apathy, 
however, are not well understood. To improve understanding of apathy, we examined the 
neural basis of GDB in bvFTD. Eighteen apathetic bvFTD participants and 17 healthy 
controls completed the PACT. This test quantifies each of three components of GDB—
initiation, planning, and motivation—hypothesized to contribute to apathy. We then 
analyzed the association between PACT scores with grey matter atrophy and reduced 
white matter FA in bvFTD. Compared to controls, bvFTD participants demonstrated 
significant impairments in the three hypothesized components of GDB that contribute to 
apathy. Regression analyses related each component to disease in specific grey matter 
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structures and associated white matter tracts. Poor initiation related to grey matter 
atrophy in anterior cingulate and reduced FA in cingulum. Planning impairment related to 
grey matter atrophy in dlPFC and reduced FA in superior longitudinal fasciculus. Poor 
motivation related to grey matter atrophy in orbitofrontal cortex and reduced FA in 
uncinate fasciculus. bvFTD patients have difficulty with initiation, planning, and 
motivation components of GDB. These findings are consistent with the hypotheses that 
GDB encompasses three processes, that these are supported by a large-scale neural 
network in specific portions of the frontal lobe, and that degradation of any one of these 
prefrontal regions in bvFTD may contribute to apathy. 
Introduction 
Apathy is among the most common behavioral manifestations that contribute to 
bvFTD (Diehl-Schmid et al., 2006). However, the mechanisms that contribute to apathy 
are poorly characterized. We hypothesize that apathy can be operationalized as an 
impairment in GDB that is essential to daily human functioning. GDB defined as “broad 
spectrum of purposeful actions, from the simplest movement to the most complex 
patterns of behavior” (Brown & Pluck, 2000, p. 416)—includes mechanisms such as 
initiation, planning, and motivation, which allow a person to direct purposeful behavior 
toward a desirable goal or away from an undesirable outcome (Geurts & de Wit, 2013). 
In this study, we examined dissociable behavioral and neuroanatomic components of 
GDB in bvFTD in an effort to improve understanding of apathetic behavior. 
Most studies of bvFTD assumed that apathy is a single, undifferentiated 
behavioral phenomenon. Using a unitary model, researchers have linked apathy in 
bvFTD to several prefrontal areas, including dorsolateral, anterior cingulate, and orbital 
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regions (Massimo et al., 2009; Zamboni et al., 2008). Heterogeneous findings such as 
these may reflect that apathy is multifactorial, consistent with the GDB model, and that 
each of these anatomic regions supports one component of a large-scale network that may 
be compromised in bvFTD patients who display apathy. In the present study, we used a 
novel RT test that directly ascertains each of three components thought to play a role in 
GDB, and we relate patterns of impairment for each component to MRI regions of grey 
matter atrophy and white matter integrity in bvFTD. 
Methods 
Participants. Eighteen bvFTD patients (five women) were recruited from the 
outpatient clinic of the Department of Neurology, University of Pennsylvania and 
evaluated by experienced cognitive neurologists (DJI, MG) using published consensus 
criteria (Rascovsky et al., 2011). All patients had mild disease (MMSE ≥ 20) to minimize 
potential confounding factors related to severe cognitive impairment. Medical and 
psychiatric causes of dementia were excluded by clinical examination and blood- and 
brain-imaging tests. We also excluded individuals with depression using the Geriatric 
Depression Scale-Short Form (Sheikh & Yesavage, 1980) scores > 5, as depression can 
be confused with apathy, and we excluded participants taking benzodiazepines and other 
soporific medications because of their sedating side effects. All participants had apathy, 
determined by the NPI (Cummings et al., 1994) FxS score >1. The FxS score is rated on 
the basis of scripted questions administered to the patient’s caregiver, yielding a 
maximum score of 12. Caregiver also rate their own levels of distress for each domain. 
Seventeen healthy seniors served as a control group for the behavioral measure. Control 
participants were demographically-comparable to bvFTD participants for age and 
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education and self-reported a negative neurological or psychiatric history. See Table 6 for 
a summary of demographic characteristics. All participants and responsible caregivers for 
patients participated in an informed-consent procedure approved by the University of 
Pennsylvania IRB. 
Table 6 
Mean (+S.D.) Demographic and Clinical Features of Patients with Behavioral Variant 
Frontotemporal Degeneration and Healthy Controls 
 Controls (n = 17) bvFTD (n = 18) 
Age (Years) 67.12±10.82 61.00± 5.2 
Education (Years) 15.35±2.91 17.00± 3.1 
Disease duration (Years) na 3.70±1.63 
Mini-Mental State Exam 
(max score=30) 
29.47±0.87 27.33±2 .2 
 
Behavioral measures. 
The Philadelphia Apathy Computerized Test (PACT). The PACT was developed 
to quantify components of GDB that are compromised in patients with apathy. It was 
developed based on a review of experimental paradigms in the literature and clinical 
observations of apathy (Jenkins et al., 2000; Ruh et al., 2010). Briefly, a computerized 
RT was obtained to assess initiation, planning, and motivation components of GDB. 
Participants had a brief practice period of several trials for each of the measures described 
below, and all participants appeared to understand the tasks. 
To assess the initiation component, participants began a trial by depressing the 
“start” key, then a central visual stimulus (triangle) appeared on the computer screen 
(latency ranging pseudorandomly 500–1,200msec); finally, another fixed central target 
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key must be depressed in response to this stimulus for 48 trials. To obtain an initiation 
score, we measured the latency for the subject to lift the finger off of the start key in 
response to the stimulus on the screen. 
Assessing the planning component required a resource-demanding task that 
depended on the integration of strategies to meet the challenges of the condition (Sorel & 
Pennequin, 2008; Toglia & Berg, 2013). Here, participants must correctly press one of 
two pseudorandomly lateralized keys, contingent on the combination of two features of a 
central visual-pattern stimulus: if the stimulus is blue or has horizontal stripes, the key on 
the left is correct; if the stimulus is orange or contains vertical stripes, the key on the right 
is correct. To assure that planning could be assessed specifically, we minimized the 
influence of working memory confounds by making the patterns visually available to 
participants during performance. A planning score was generated by averaging the total 
latencies on correct trials of the planning task described above. 
To assess the motivation component, the participant performed the initiation task 
described above; here, we gave participants an additional amount of money in the form of 
monetary units at the beginning of the task, and money was taken away as a “penalty” if 
they did not respond more rapidly to a stimulus relative to their previous performance, 
obtained during the initiation task described above. Participants received verbal and 
visual feedback (a bank of points appeared on the screen) about their response speed after 
each trial on the computer screen, compared to their prior RT, and we told participants 
that monetary units would be converted to money at the end of the study. Participants 
also performed a “reward” condition where they receive points for responding more 
rapidly than during the initiation condition (reward and penalty conditions were 
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administered in a randomly ordered manner across participants, but we used the penalty 
condition to obtain a motivation score because previous work has shown that bvFTD 
patients are particularly insensitive to negative feedback (Grossman et al., 2010). 
Neuroimaging data. Structural MRI data were available for all bvFTD 
participants with PACT scores (n = 18), and DTI data from the same scan session were 
also available for a subset of these participants (n = 15). We acquired high-resolution T1-
weighted 3-dimensional spoiled gradient echo images on a Siemens 3.0T Trio scanner 
with an 8-channel coil (repetition time = 1,620msec, echo time = 3msec, slice thickness = 
1.0mm, flip angle = 15°, matrix = 192 × 256, and in-plane resolution = 0.9 × 0.9mm). We 
acquired DWI using a single-shot, spin-echo, diffusion-weighted echo planar imaging 
sequence (FOV = 245mm; matrix size = 128 × 128; number of slices = 57; voxel size = 
2.2mm isotropic; TR = 6,700ms; TE = 85ms; fat saturation). In total, we acquired 31 
volumes per subject, one without diffusion weighting (b = 0 s/mm2) and 30 with diffusion 
weighting (b = 1,000 s/mm2) along 30 noncollinear directions. For comparison, we 
selected a standardized sample of 24 controls with existing MRI and DTI. Two sample 
t-tests confirmed that patients and controls [mean age = 60.71 years (SD = 6.9); mean 
education = 15.79 years (SD = 1.9)] were demographically comparable (age, education, 
and gender, all p > .1). To ensure our imaging control cohort was representative of the 
behavioral control cohort, we performed two-sample t-tests and confirmed that these 
groups were demographically comparable (age, education, and gender, all p > .1). 
Grey matter imaging data. Before normalization, we segmented each individual’s 
structural image into tissue classes using Atropos, a voxel-based segmentation tool that 
segments the brain into grey matter, white matter, and cerebrospinal fluid (Avants, 
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Tustison, Wu, Cook, & Gee, 2011). We preprocessed all images using PipeDream 
(Sourceforge, 2014) and ANTS (Penn Image Computing & Science Lab. 2014) to 
perform multivariate normalization. Researchers demonstrated that this method 
accurately normalizes large-scale data in studies of patients with ND (Avants et al., 2008; 
Avants, Tustison, Song, et al., 2011). We used a diffeomorphic deformation for 
registration that is symmetric so it is not biased toward the reference space for computing 
the mappings (Avants, Tustison, Song, et al., 2011). Processing involved mapping T1 
structural MRI to an unbiased average-shape and average-appearance template derived 
from a representative population consisting of 25 healthy seniors and 25 patients with 
FTD (J. Kim et al., 2008) This diffeomorphic method for registration and normalization 
avoids the need to use identical participants in the local template. Grey matter probability 
images were calculated as a quantitative measure of grey matter density. We then 
transformed grey matter probability images into Montreal Neurological Institute space for 
statistical analysis and down-sampled to 2mm3 resolution to attain a more anatomically 
relevant voxel size. 
We used SPM8 (SPM, 2014) to smooth grey matter images using a 5mmFWHM 
Gaussian kernel. We conducted a whole-brain analysis: First, we compared grey matter 
density in bvFTD and 24 healthy seniors using a two-sample t-test with a voxel level 
threshold of p < .001 (FDR-corrected) and extent threshold of 50 voxels. In the second 
analysis, we performed regressions to relate grey matter density in bvFTD directly to the 
scores (initiation, planning, and motivation) on the PACT. We restricted regression 
analyses to evaluate only potential relationships between PACT performance and regions 
demonstrated to be atrophied in our bvFTD sample in an effort to constrain our 
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interpretations of the regression analyses to those brain regions known to be significantly 
atrophic and highly likely to have disease. For example, a significant correlation between 
a nonatrophied area and a PACT score could otherwise be attributed to factors that are 
independent from disease and instead related to nonspecific factors such as age. The 
height threshold for the regression analyses was set at p < .005 (uncorrected). The 
threshold was set at p < .05 for the planning regression due to limited variance in 
planning scores. We accepted as significant a cluster with a volume of 30 adjacent voxels 
and a peak voxel Z-score > 3.09 (equivalent to p < .001). 
White matter imaging. DWIs were preprocessed with PipeDream and ANTS, as 
above. We removed motion and distortion artifacts by affine coregistration of each DWI 
to the unweighted (b = 0) image. We computed DTs using a linear least squares algorithm 
(Salvador et al., 2005) implemented in Camino (Cook et al., 2006), and reoriented tensors 
using the preservation-of-principal-directions algorithm (D. C. Alexander et al., 2001). 
We computed FA from the DT image for each subject, correcting distortion between T1 
and DT images by registering the FA image to the T1 image. We warped each 
participant’s T1 image to the template via the symmetric diffeomorphic procedure in 
ANTS; then warped the FA image to template space by applying the T1-to-template 
warps. 
We smoothed FA images using a 4mm FWHM isotropic Gaussian kernel. We 
performed DTI analyses of FA in SPM8 using the two-samples t-test module. We 
analyzed DTI volumes using an explicit mask (FA > 0.25) to constrain comparisons to 
regions of white matter. To compare bvFTD participants to healthy seniors, we used a 
p < .005 (FDR-corrected) height threshold and a 200-voxel extent. We constrained 
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regression analyses to white matter tracts with reduced FA using an explicit mask 
generated from the results of the direct comparison with healthy seniors. We limited our 
analyses to white matter tracts with significant disease, as above, to constrain our 
interpretation to disease-specific neuroanatomical regions. Using a deterministic 
tractography procedure in Camino (Cook et al., 2006) we tracked white matter fibers in a 
healthy elderly template generated using the DTI sequence described above. We retained 
fiber tracts that passed through voxels of reduced FA to define the mask for regression 
analyses and accepted as significant a cluster with a volume of 150 adjacent voxels and a 
peak voxel Z-score > 3.3 (equivalent to p < .0005). 
Results 
Behavioral data results. Mean apathy FxS score on the NPI for the bvFTD group 
was 5.27 ± 3.3. Mean caregiver distress associated with apathy was 2.77 ± 1.4. Caregiver 
distress scores and FxS scores were moderately correlated (rho = 0.53; p = .03). 
Table 7 summarizes the performance on the PACT measures. Between-group 
comparisons revealed that apathetic bvFTD participants had slower latencies than NC on 
all three measures of GDB: initiation (t[33] = 2.26, p = .03; planning (t[33] = 4.79, 
p < .001; and motivation (t[33] = 2.17, p = .03). 
Table 7 
Mean (S.D.) Reaction Time Scores for PACT Performance 
PACT score Control (n = 17) bvFTD (n = 18) p-value 
Initiation 364.2ms ± 54.0 587.50ms ± 404.3 .03 
Planning 1023.76ms ± 139.9 1754ms ± 612.5 < .001 
Motivation 522.31ms ± 113.6 916ms ± 715.5 .03 
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Imaging results. 
Grey matter imaging. Figure 1 illustrates widespread reduction in grey matter 
density (green) in lateral (Panel A) and medial (Panel B) frontal and temporal regions in 
bvFTD compared to controls. Table 8 summarizes the location of peak voxels in 
significantly atrophic clusters. 
The results of the regression analysis relating PACT performance to reduced grey 
matter density are also summarized in Table 8. Initiation performance was related to 
ACC (Figure , Panel C, purple). Planning performance was related to dlPFC (Figure 1, 
Panel D, red). Motivation performance was related to OFC (Figure 1, Panel E, blue). 
 
Figure 1. Significant atrophy in behavioral variant frontotemporal degeneration, and 
regressions relating Philadelphia Apathy Computerized Test performance to grey matter 
density (n = 18)1. 
Note: 1. Panel A and B: Anatomic distribution of significant grey matter atrophy in 
participants with behavioral variant frontotemporal degeneration (green). Panel C: 
Significant regressions relating initiation performance to cortical atrophy in anterior 
cingulate (purple) at y = 40. Panel D: Significant regressions relating planning 
performance to cortical atrophy in dorsolateral prefrontal cortex (red) at y = 22. Panel E: 
Significant regressions relating motivation performance to cortical atrophy in 
orbitofrontal cortex (blue) at y = 42. See text and Table 8 for details. 
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Table 8*** 
Anatomic Locus of Peak Voxels in Clusters Relating PACT Scores to Grey Matter 
Atrophy (n = 18) and White Matter Integrity in bvFTD (n = 15)  
Anatomic locus 
(BRODMANNAREA)1 
MNI coordinates2 Z-score of peak 
voxel 
Cluster size 
(voxels) X Y Z 
behavioral variant frontotemporal degeneration < Eld (grey matter atrophy) 
L superior frontal gyrus (10) -22 46 26 4.65 96 
R rostral prefrontal (11) 22 52 4 5.17 362 
R middle frontal gyrus (9) 20 26 38 5.06 106 
R inferior frontal gyrus (44) 40 8 28 5.84 401 
L insula -22 20 -6 4.69 194 
R subcallosal gyrus (25) 16 18 -8 5.24 524 
R parahippocampal gyrus (27) 18 -34 -2 6.25 14067 
R fusiform gyrus (20) 40 -34 -20 4.51 99 
R middle temporal gyrus (20) 58 -32 -18 4.70 94 
R inferior temporal gyrus (37) 54 -52 -10 4.90 149 
R inferior parietal lobule (40) 34 -34 38 5.10 64 
behavioral variant frontotemporal degeneration Initiation Regression (grey matter) 
R dorsal anterior cingulate gyrus (32) 22 16 42 4.87 52 
L dorsal anterior cingulate gyrus (32) -14 42 14 4.30 74 
behavioral variant frontotemporal degeneration (grey matter) 
R middle frontal gyrus (9) 22 14 44 3.28 56 
L middle frontal gyrus (11) -20 40 -22 3.10 104 
behavioral variant frontotemporal degeneration Motivation Regression (grey matter) 
L medial orbital frontal gyrus (11) -4 44 -16 4.61 42 
R inferior frontal gyrus (46) 40 38 10 3.90 42 
R inferior frontal gyrus (47) 34 34 2 3.17 78 
L inferior frontal gyrus (47) -48 24 -6 3.52 34 
R cingulate gyrus (32) 22 18 40 5.41 63 
L cingulate gyrus (32) -14 42 14 4.16 77 
 
behavioral variant frontotemporal degeneration < Eld (reduced fractional anisotropy) 
L uncinate fasciculus -33 2 -9 6.30 13222 
R uncinate fasciculus 38 7 -28 5.15 1388 
L inferior frontal gyrus white matter -34 14 22 5.87 7623 
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Anatomic locus 
(BRODMANNAREA)1 
MNI coordinates2 Z-score of peak 
voxel 
Cluster size 
(voxels) X Y Z 
R cingulum 3 -21 30 4.60 355 
R anterior corona radiata 11 34 -13 4.54 1244 
Body of corpus callosum -7 6 25 4.44 1546 
R column and body of fornix 3 -8 16 6.42 541 
L posterior limb of internal capsule -18 -8 5 4.17 347 
L crus of fornix or striaterminalis -14 -30 13 4.76 261 
Splenium of corpus callosum 12 -33 11 5.15 1220 
R inferior temporal gyrus white matter 47 -48 -13 5.10 335 
behavioral variant frontotemporal degeneration Initiation Regression (fractional anisotropy) 
L cingulum -7 30 15 3.43 1693 
Body of corpus callosum 2 8 25 3.52 Same cluster as 
cingulum 
Genu of corpus callosum 13 52 14 4.03 1056 
Genu of corpus callosum -12 53 23 3.39 382 
R uncinate fasciculus 16 39 -16 4.84 2587 
L medial orbital gyrus white matter -14 32 -16 4.29 4609 
behavioral variant frontotemporal degeneration Planning Regression (fractional anisotropy) 
R superior longitudinal fasciculus 25 -40 34 3.47 191 
L inferior frontal gyrus white matter -49 31 5 3.54 217 
R inferior frontal occipital fasciculus 18 25 -3 5.10 1092 
Genu of corpus callosum 12 47 26 4.23 650 
Body of corpus callosum 15 15 42 3.82 533 
Body of corpus callosum 10 6 58 3.74 162 
R posterior corona radiata 20 -26 37 3.93 258 
L superior corona radiata -20 -14 38 3.54 269 
L. cingulum -5 -8 37 3.45 239 
behavioral variant frontotemporal degeneration Motivation Regression (fractional anisotropy) 
R uncinate fasciculus 16 39 -16 4.67 2537 
L medial orbital gyrus white matter -13 33 -16 3.98 1678 
Genu of corpus callosum 16 51 15 3.92 1091 
Genu of corpus callosum 2 25 7 3.77 2593 
Note. 1. The corresponding Brodmann area is indicated by the figure in parentheses. L = left; R = right. 2. 
Peak locus of these clusters are derived from MNI (= Montreal Neurological Institute) space converted to 
Talairach space using Montreal Neurological Institute. 
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White matter imaging. bvFTD showed widespread reductions in FA in bilateral 
frontal and temporal white matter relative to controls (Figure 2, Panel A, green). Peak 
voxels in clusters of significantly reduced FA, and regressions of FA with PACT scores 
are summarized in Table 8. Initiation performance was related to FA in cingulum, UNC 
fasciculus, inferior longitudinal fasciculus, and corpus callosum (CC) (Figure 2, Panel B, 
purple). Planning performance was related to FA in superior longitudinal fasciculus 
(SLF), right inferior frontal-occipital fasciculus, rostral frontal corona radiata, and CC, as 
well as posterior thalamic radiations (Figure 2, Panel C, red). Finally, motivation 
performance was related to FA in UNC as well as CC, corona radiata , and inferior 
longitudinal fasciculus (Figure 2, Panel D, blue). 
 
Figure 2. Reduced white matter integrity in behavioral variant frontotemporal 
degeneration, and regressions relating Philadelphia Apathy Computerized Test 
performance to reduced fractional anisotropy (n = 15)1. 
Note: 1. Panel A: Anatomic distribution of reduced fractional anisotropy in participants 
with behavioral variant frontotemporal degeneration (green). Panel B: Significant 
regressions relating initiation performance to reduced fractional anisotropy including 
cingulum (purple). Panel C: Significant regressions relating planning performance to 
reduced fractional anisotropy including right superior longitudinal fasciculus (red). Panel 
D: Significant regressions relating motivation performance to reduced fractional 
anisotropy in uncinate fasciculus (blue). See text and Table 2.3 for details. 
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Discussion 
This study investigated the behavioral and neural basis of GDB by examining 
bvFTD patients who display prominent apathy. We found that apathetic bvFTD patients 
are impaired on each of the three processes thought to contribute to apathy due to deficits 
in GDB: initiation, planning, and motivation. These three GDB processes were associated 
with disease in three distinct frontal grey matter regions and in white matter projections 
between these regions and other brain areas. Specifically, initiation difficulty related to 
atrophy in the ACC and to disease in the cingulum, poor planning related to atrophy in 
dlPFC and disruption in SLF and frontal corona radiata, and impoverished motivation 
related to atrophy in OFC and UNC disease. These findings are consistent with a three-
component model of GDB that can contribute to apathy in bvFTD. 
The PACT identified impairment in the three components of GDB: initiation, 
planning and motivation. A deficit in any one of these can contribute to apathy in bvFTD. 
Moreover, each of these deficits was associated with selective disruption of a large-scale 
neuroanatomic network important for GDB. Consider first a deficit in initiating a 
behavior that is related to ACC and white matter tracts including the cingulum. 
Considerable work has suggested that the ACC is important to initiate a behavior (Tekin 
& Cummings, 2002). Researchers previously implicated the ACC in processes that 
influence action initiation in healthy adult studies (Mulert, Gallinat, Dorn, Herrmann, & 
Winterer, 2003). Others implicated the ACC in initiation difficulty in those with frontal 
lobe injury. For example, the akinetic mute state is a medical term describing patients 
who tend to sit quietly in the same position all day without speaking or talking, and 
researchers related this specifically to ACC damage (Mega & Cohenour, 1997). The ACC 
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has been well studied in dementia, and neuroimaging evaluations have linked the ACC 
region to apathy in various groups. Researchers associated reduced grey matter density in 
the cingulate gyrus with apathy in patients with bvFTD (Massimo et al., 2009; Zamboni 
et al., 2008) and PD (Reijnders et al., 2010). Previous DTI studies investigating white 
matter disease and apathy showed an association with the cingulum, which has reciprocal 
connections between ACC and the medial orbitofrontal region that is important for 
motivation (Hahn et al., 2013; Ota et al., 2012). In healthy adults, ACC and dlPFC 
structures work in concert during complex tasks that require attentional control, likely to 
be mediated through the cingulum (Silton et al., 2010). Therefore, disease in ACC and 
interruption of projections between ACC and other structures important for GDB may 
contribute to apathetic behavior. 
Researchers associated deficits in the planning component of GDB with atrophy 
in the dlPFC and reduced FA in related white matter tracts, including SLF and frontal 
corona radiata. fMRI studies of healthy adults suggested that dlPFC contributes to 
planning and working memory (Di, Rypma, & Biswal, 2013). Patients who suffer from 
dysfunction in these circuits failed to elaborate, manipulate, and integrate important 
information needed for behavior that is goal-directed. Studies suggested a relationship 
between apathy and poor executive function in bvFTD (Eslinger et al., 2012; Zamboni et 
al., 2008). Eslinger and colleagues (2012) found caregiver apathy scores were 
significantly correlated with executive-function measures, suggesting that apathy 
emanates in part from difficulty manipulating and integrating elements of a plan to 
achieve a goal (Eslinger et al., 2012). Imaging studies of patients with FTD and AD have 
linked apathetic behavior to atrophy in dlPFC as well (Massimo et al., 2009; Zamboni et 
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al., 2008). In addition, a previous study of patients with amnestic mild cognitive 
impairment revealed a relationship between reduced FA in the SLF and apathy (Cacciari 
et al., 2010). The SLF is a prominent white matter tract interconnecting the frontal, 
temporal, and parietal lobes, and this tract has been implicated in the integration of these 
diverse regions involved in planning (Genova, DeLuca, Chiaravalloti, & Wylie, 2013). 
We found that difficulty with the motivation component of GDB is associated 
with atrophy in the OFC and related white matter tracts, including UNC. Evidence from 
healthy subject fMRI studies suggested that the OFC plays a role in interpreting value 
and reward-related information (Hare et al., 2010). Researchers have examined deficits in 
processing value and reward extensively in patients with FTD because they appear to 
have early degeneration of this frontal circuit in comparison to other neurodegenerative 
conditions (Rabinovici et al., 2007). Poor motivation can occur in these patients because 
they have decreased reactivity to positive “reward” and negative “punishment” signals, 
thereby making goal-selection difficult (Levy & Dubois, 2006). Experimental evidence, 
however, emphasized that patients with bvFTD and other diseases affecting OFC have 
the greatest difficulty interpreting “punishment” signals (Grossman et al., 2010). Imaging 
evidence from patients with bvFTD emphasized the link between OFC and apathetic 
behavior (Massimo et al., 2009). Fludeoxylucose PET brain activity is decreased in OFC 
in bvFTD patients with apathetic compared to nonapathetic patients (Peters et al., 2006). 
UNC is a major tract connecting the anterior temporal lobe with the medial and lateral 
prefrontal cortex areas known to be important for GDB (Kable & Glimcher, 2007). DTI 
studies performed in AD and PSP implicated UNC in apathy (Hahn et al., 2013) and our 
findings extend this to bvFTD. 
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Although we suggest specific contributions of neural mechanisms to distinct 
components of GDB, we do observe some overlap across measures. For example, our 
grey matter observations suggested that the cingulate may contribute to both initiation 
and motivation. In fact, post hoc correlation analyses of PACT measures revealed a 
significant correlation between initiation and motivation performance (rho = .78; 
p < .001). Post hoc correlations, however, are not significant between other PACT 
measures (all p > .05, Bonferroni corrected) and we otherwise observed distinct 
neuroanatomical regions contributing to components of GDB. It will be important for 
future work to identify quantitative measures of initiation and motivation that are not 
interdependent. 
This is the first study using the impaired GDB model to help explain apathy in 
ND, and our findings have potentially important implications for its treatment. Prior 
measures to manage apathy have not been effective (Mizrahi & Starkstein, 2007). One 
reason for this failure may be the way apathy is conceptualized. That is, apathy is 
currently viewed homogeneously, as if derived from a single source; our findings suggest 
that each of three components of GDB contribute to apathetic behavior. Treatments, thus, 
have tended to focus on improving the initiation component of GDB, often with 
stimulants (Devos et al., 2013), even though apathy may be due to a deficit in one of the 
other components of GDB. 
Some limitations should be kept in mind when considering our findings. Although 
our sample was larger than in prior investigations of apathy, we nevertheless studied a 
small number of patients and power in the imaging studies may have been insufficient to 
detect every anatomic region associated with apathy. Because floor effects in performing 
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the planning measure limited variance, we were forced to use a liberal threshold for our 
hypothesis-driven grey matter analyses. Last, we do not have neuropathological 
confirmation of the diagnoses of these patients. 
With these caveats in mind, we conclude that apathetic behavior in bvFTD can be 
characterized as an impairment in GDB that is a multicomponent process including 
initiation, planning, and motivation. These three processes are supported by a large-scale 
neural network constituting the neuroanatomic basis for GDB, including distinct grey 
matter regions in the frontal lobe and related white matter projections. 
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Abstract 
Apathy involves a reduction in GDB. In the current study, we sought to identify 
three subtypes of apathy in bvFTD by differentiating impairments in GDB. Twenty 
patients with bvFTD and 17 matched healthy controls participated in this study. We 
measured RTs using a novel computerized procedure—PACT—to quantify performance 
for each of three components of GDB—initiation, planning, and motivation—and to 
derive individualized patient-apathy profiles. We explored neuroanatomical associations 
of these performance profiles using a region of interest volumetric analysis. We found 
isolated deficits in each component of GDB in 12 (60%) bvFTD participants, including 
two (10%) with an isolated initiation impairment, eight (40%) with an isolated planning 
impairment, and two (10%) with an isolated motivation impairment. An additional eight 
(40%) participants were impaired on multiple components of the PACT. Voxel-based 
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morphometry revealed that those participants with reduced initiation had ACC atrophy; 
those with impaired planning had atrophy in dlPFC, and those with poor motivation had 
OFC atrophy. Apathy is a complex, multicomponent syndrome, and we found 
quantitative reduction in each of the three processes contributing to apathy in bvFTD. 
Introduction 
GDB describes a set of related processes that support independent, goal-obtaining 
action in everyday activities (Brown & Pluck, 2000). Core components of GDB include 
initiation, planning, and motivation. We adopted the perspective that apathy is a 
reduction in GDB which arises when one or more GDB processes are compromised 
(Levy & Dubois, 2006). We developed a quantitative measure to directly assess the 
behavioral and neuroanatomic basis for apathy in bvFTD. 
Apathy is reported to be the most common initial behavioral syndrome in bvFTD, 
occurring in up to 90.5% of  patients (Diehl-Schmid et al., 2006). Researchers associated 
akinetic mutism and abulia that emphasize a lack of initiation with apathy (Starkstein & 
Leentjens, 2008). Further, others related apathy to executive deficits that limit planning 
needed for goal-obtaining actions (Eslinger et al., 2012). Still others have broadly defined 
apathy as reduced motivation (Marin, 1996). Each of these characteristic behaviors can 
be seen in apathetic bvFTD patients. We assessed initiation, planning, and motivation 
components of GDB using a novel computerized RT test—PACT—in apathetic patients 
with bvFTD. 
Researchers think apathy arises following degeneration of frontal-subcortical 
circuits (Levy & Dubois, 2006). Consistent with the view that a single-component model 
may be insufficient to explain apathy, neuroimaging studies associate apathy with several 
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frontal regions (Massimo et al., 2009; Rosen et al., 2005; Zamboni et al., 2008). Previous 
imaging studies in persons without apathy suggested that poor initiation relates to ACC disease, 
(Kotchoubey et al., 2003; Reijnders et al., 2010); poor planning relates to disease in dlPFC, 
(Kaller et al., 2011; Unterrainer, Rahm, Kaller, Leonhart, et al., 2004; van den Heuvel et al., 
2005), and reduced motivation relates to disease in OFC (Diekhof et al., 2011; Sescousse et al., 
2010). A specific process of GDB suffers when one of these frontal areas is compromised, 
resulting in apathetic behavior. We hypothesized that patients with bvFTD have 
differentiated profiles of apathy, and that these relate in part to patients’ neuroanatomic 
distribution of disease. 
Methods 
Participants. We examined 20 apathetic patients with bvFTD (female = 5) and 
17 demographically matched healthy controls (NC). Experienced cognitive neurologists 
from the Department of Neurology, University of Pennsylvania (MG, DJI) evaluated and 
recruited all patients. bvFTD patients were diagnosed using published criteria (Rascovsky 
et al., 2011). Neurologists assessed patients as having apathy based on the apathy 
subscale of the NPI using an FxS score ≥ 1. As summarized in Table 9, we included only 
participants with mild disease (MMSE ≥ 20) to minimize confounding factors related to 
severity of cognitive impairment. Geriatric Depression Scale-Short Form (Sheikh & 
Yesavage, 1980) scores ≤ 5 demonstrated that participants were not depressed, as 
depression also could confound our findings. All subjects and responsible caregivers 
participated in an informed-consent procedure approved by the University of 
Pennsylvania IRB. 
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Table 9 
Mean (S.D.) Demographic Features of Participants 
 NC (n = 17) bvFTD (n = 20) 
Age (YEARS) 67.12±10.82 63.1±5.88 
Education (Years) 15.35±2.91 16.65±2.79 
Mini-Mental State Exam (max score = 30) 29.47±0.87 26.45±2.48 
Disease duration (Years) na 3.4±1.64 
Mean Neuropsychiatric Inventory 
Apathy frequency by severity (max score = 
12) 
na 
5.54±3.1 
 
The initial clinical diagnosis of bvFTD was consistent with results of serum 
studies, structural imaging such as MRI or CT, studies of cerebrospinal fluid, and 
functional neuroimaging studies such as single-photon emission computerized 
tomography or PET (when available). Exclusion criteria included the presence of other 
neurological conditions such as stroke, closed-head trauma, or hydrocephalus; primary 
psychiatric disorders such as depression or psychosis; a systemic illness that can interfere 
with cognitive functioning; or use of soporific medications because of their sedating side-
effects. Patients may have been taking a fixed dosage of a cholinesterase inhibitor (e.g., 
donepezil, rivastigmine, or galantamine) or memantine, or a low dosage of a nonsedating 
antidepressant (e.g., serotonin-specific reuptake inhibitors such as sertraline) or an 
atypical neuroleptic agent (e.g., quetiapine), indicated clinically. 
The Philadelphia Apathy Computerized Test (PACT). The PACT is a novel 
computerized RT test designed to quantify each core component of GDB: initiation, 
planning, and motivation. The PACT was developed based on a review of experimental 
paradigms and clinical observations (Elliott et al., 2010; Jenkins et al., 2000; Ruh et al., 
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2010). There are 48 trials in each of the three conditions, one for each GDB component. 
A practice block, in which participants receive instructions about task performance and 
12 practice trials, precedes each experimental condition. 
In each condition, a trial begins when the subject depresses a computer “start” key 
with the index finger. In response to a signal, RT1 is the latency for a participant to lift 
the finger from the start key, and RT2 is measured as the time to depress the target key 
after lifted from the start key. Total latency is the sum of RT1 and RT2. We 
counterbalanced all stimuli and randomly distributed them in each condition. 
In the simplest condition, designed to measure the initiation component, a 
participant begins a trial by depressing the start key; when a stimulus appears centrally on 
the computer screen, the participant lifts the finger from the start key, then depresses a 
fixed central target key in response to this stimulus; the signal occurs on average 
1,250msec (range 500–2,000msec) after depressing the start key. Initiation is assessed by 
measuring RT1. 
To measure the planning component, we administered two levels of task difficulty. 
In the first level, participants depress the start key and then are presented with randomly 
ordered lateralized visual stimuli on the computer screen. Participants are instructed to 
press a left or right target key (stimulus appears on the left, then go left; stimulus appears 
on right, then go right. In the second, more complex level, one of two lateralized keys is 
pressed contingent on the combination of patterns in a central visual stimulus (stimulus 
appears on the left, then go left; stimulus appears on right, then go right). These patterns 
are visually available to participants during performance to minimize task-related 
working memory confounds. We used two measures to identify a planning deficit: total 
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latency in the complex planning condition and the difference in response times between 
these two levels of difficulty. 
To assess motivation, we repeated the simplest condition with an explicit 
monetary reward incentive; a system of “monetary units,” was exchanged for actual 
money at the end of the study, for responding correctly and more rapidly than during the 
simple task. Participants see their response speed during the unrewarded condition on the 
computer screen, and receive feedback about their “rewarded” response speed on the 
computer screen after each trial. Sensitivity to negative consequences is also assessed 
with a “penalty” condition. In this “penalty” condition, participants are given a number of 
monetary units at the beginning of the task. If they do not respond correctly and more 
rapidly, they lose units. We use the total latency in the penalty condition to assess 
motivation because previous work has shown that bvFTD patients appear to be relatively 
insensitive to negative feedback (Grossman et al., 2010). The point system was adjusted, 
without knowledge of the participant, so that each participant received the same total 
actual payment at the end of the study. 
Behavioral criteria for developing apathy subtypes. We developed 
performance profiles according to predetermined criteria that correspond to each of the 
components of GDB, and these were ascertained in individuals using latency means and 
standard deviations over 48 trials in each of the three experimental conditions (see Table 
10). Individual participant z-scores were generated for NC performance for each 
condition. Significant impairments were defined as a z-score ≥ 2 for each component. 
Most participants with impairments in initiation and/or motivation also had a planning 
impairment, consistent with the dysexecutive profile typically seen in bvFTD (Rascovsky 
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et al., 2011). For participants whose impairment was limited to planning, we assumed this 
component was the sole contributor to apathy. To better distinguish which components 
contributed most to apathy in those with multiple impairments, we implemented the 
application of the planning criteria in a stepwise fashion. Thus, we subjected planning-
impaired participants who also had deficits in initiation and/or motivation to a second 
level review; we only classified those participants who also had greater slowing on the 
complex planning condition compared to the simpler planning condition in the planning-
impairment subtype. 
Table 10 
Behavioral Criteria for Apathy Subtypes  
Subtype profile Criteria 
Initiation Significantly slow Reaction Time 1 in simple condition 
Does not have slowed latencies for complex condition 
Able to improve performance on the simple condition in response to penalty. 
Planning Significantly slowed on complex planning condition and, for those with multiple 
impairments, significant slowing on the complex planning condition compared to the 
simpler planning condition 
Does not have slowed initiation for simple condition 
Able to improve performance on the simpler planning condition in response to reward 
or “penalty.” 
Motivation Significantly slowed on simple penalty condition and fails to improve performance 
with penalizing motivators 
Does not have slowed initiation for simple condition 
Does not have slowed latencies for complex condition. 
 
Neuroimaging data. High-resolution T1-weighted 3-dimensional spoiled 
gradient echo images were acquired on a Siemens 3.0T Trio scanner with an 8-channel 
coil (repetition time = 1,620msec, echo time  = 3msec, slice thickness = 1.0mm, flip 
angle = 15°, matrix = 192 × 256, and in-plane resolution = 1.0 × 1.0mm). Before 
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normalization, each participant’s structural image was segmented into tissue classes using 
Atropos, a voxel-based segmentation tool that segments the brain into grey matter, white 
matter, and cerebrospinal fluid (Avants, Tustison, Wu, et al., 2011). We preprocessed all 
images processed using PipeDream (Sourceforge, 2014) and ANTS (Penn Image 
Computing & Science Lab, 2014). Researchers previously demonstrated the ability of 
this method to accurately normalize large-scale data as in studies of patients with ND 
(Avants et al., 2008; Avants, Tustison, Song, et al., 2011). We used a symmetric 
diffeomorphic deformation for registration to avoid bias toward the reference space for 
computing the mappings (Avants, Tustison, Song, et al., 2011). Processing involved 
mapping T1-weighted structural MRI to an unbiased average-shape and average-
appearance template derived from a representative population consisting of 25 healthy 
seniors and 25 patients with FTD (J. Kim et al., 2008). This diffeomorphic method for 
registration and normalization avoids the need to use identical participants in the local 
template (Avants & Gee, 2004). Images were then warped to Montreal Neurological 
Institute space for analysis. We calculated grey matter probability images as a 
quantitative measure of grey matter density. 
Structural MRI data were available for 19 bvFTD participants who completed the 
PACT. We obtained a priori defined ROI for ACC, dlPFC, and OFC. These ROIs were 
selected based on literature suggesting that poor initiation relates to disease in ACC 
(Kotchoubey et al., 2003; Reijnders et al., 2010), poor executive function relates to 
disease in dlPFC (Kaller et al., 2011; Unterrainer, Rahm, Kaller, Leonhart, et al., 2004; 
van den Heuvel et al., 2005), and reduced motivation relates to disease in OFC (Diekhof 
et al., 2011; Sescousse et al., 2010). We used a standardized AAL and parcellation 
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method (Tzourio-Mazoyer et al., 2002) to label the following ROIs. The first ROI (e.g., 
initiation) was centered on the ACC (AAL label = ACIN). The second (e.g., planning) 
ROI was centered on the middle frontal gyrus portion of the dlPFC (AAL label = F2). 
The last ROI (e.g., motivation) was composed of the orbital regions of the middle and 
superior frontal gyri (AAL labels = F10, F20). Additionally, we used a control ROI in the 
MT region (AAL label = T2). We chose this region because it is an area implicated in 
bvFTD (Brettschneider et al., 2014), but we did not hypothesize it to contribute to GDB. 
For all ROIs, we computer the mean GMP value and divided it by the subject’s 
individual average whole-brain GMP value. Using this ratio, we examined relative 
differences in regional composition of grey matter in frontal areas thought to underlie 
GDB impairments and the control region in the lateral temporal lobe. 
Results 
Behavioral results. Mean (SD) NPI apathy FxS score for the bvFTD group was 
5.54 ± 3.1, which suggests moderate levels of global apathy. Table 11 summarizes mean 
group performance on PACT measures. Between-group comparisons found that apathetic 
bvFTD participants have significantly slower latencies than NC on each GDB measure: 
Initiation (t[35] = 2.35, p = .03; Planning (t[35] = 5.58, p < .001; Motivation (t[35] = 2.60, 
p = .01). Although caregiver distress scores were correlated with NPI FxS scores for 
apathy, PACT scores did not correlate with either caregiver distress scores or NPI apathy 
scores. 
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Table 11 
Mean (SD) Latencies for each PACT Score in all Participants 
PACT score Control (n = 17) bvFTD (n = 20) p-value 
Initiation 364.31ms ±54.06 584.03ms ±381.60 .03 
Planning (complex 
condition) 
1023.79ms ±140.01 1845.75ms ±592.89 < .001 
Motivation (penalty 
condition) 
522.22ms ±113.54 967.67ms ±675.15 .01 
Note. PACT = Philadelphia Apathy Computerized Test; bvFTD = behavioral variant frontotemporal 
degeneration. 
Inspection of individual patient z-score profiles identified 12 patients (60%) with 
an impairment on a single GDB component. As summarized in Table 12, two (10%) had 
an initiation deficit, eight (40%) had a planning deficit, and two (10%) had a motivation 
deficit. Four patients (20%) had an initiation impairment combined with impaired 
planning or motivation, and four (20%) were impaired across all three GDB components. 
There were no differences in any demographic variables between participants with 
impairments in single or multiple components of GDB. 
Table 12 
Number of bvFTD Participants According to Apathetic Subtype (N = 20)  
Subtype N (%) 
Single component 12 (60%) 
 Initiation 2 (10%) 
 Planning 8 (40%) 
 Motivation 2 (10%) 
Multicomponent 8 (40%) 
 Initiation and planning 3 (15%) 
 Initiation and motivation 1 (5%) 
 Initiation, planning, and motivation 4 (20%) 
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Neuroimaging results. We examined differences in regional GMP in bvFTD 
participants with MRI data (n = 19) based on PACT performance. Paired samples t-tests 
were conducted to compare GMP in a priori ROIs to the control ROI in the MT region. 
Participants with any initiation deficit (n = 9) showed significantly reduced grey matter in 
the ACC region (M = 1.03, SD = 0.10) compared to the MT region (M = 1.19, 
SD = 0.02); t(8) = 3.59, p = .007). Participants with any planning deficit (n=13) showed 
reduced grey matter in the dlPFC (M = 0.99, SD = 0.04) compared to the MT region 
(M = 1.17, SD = 0.03); t(12) = 8.05, p ≤ .001). Last, participants with any motivation 
deficit (n = 10) showed reduced grey matter in the OFC (M = 1.07, SD = 0.05) compared 
to the MT region (M = 1.17, SD = 0.04), t(9) = 3.20, p = .01). 
We confirmed these findings in every participants with a single apathy deficit. 
Thus, we evaluated the specificity of these imaging results with a post hoc assessment of 
GMP in each participant with a single deficit in each apathy component. Although the 
small number of participants with single impairments precluded statistical analysis, we 
confirmed that participants with a single impairment in initiation (n = 2) had reduced grey 
matter density in the ACC compared to the MT region, participants with a single 
impairment in planning (n = 7) had reduced grey matter density in the dlPFC compared to 
the MT region, and participants with a single impairment in motivation (n = 2) had 
reduced grey matter density in the OFC compared to the MT region (see Figure 3). 
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Figure 3. Regions of interest selected from the automated anatomical labeling template. 
Note: Three parcellated gyral-based regions of interest (lateral and medial view of the 
right hemisphere). Red = anterior cingulate cortex (initiation); green = dorsolateral 
prefrontal cortex (planning); blue = orbitalfrontal cortex (motivation); 
magenta = midtemporal (control region). 
Discussion 
This study examined differentiated impairments in GDB in bvFTD patients who 
displayed prominent apathy. We identified three components of apathy based on impaired 
GDB processes defined by performance on an objective behavioral instrument: 
impairment of initiation, planning, and motivation. Our observations support that apathy 
is a multicomponent syndrome, and specific deficits in initiation, planning, and 
motivation are associated with discrete regions of the frontal lobe. 
Understanding the precise nature of the mechanisms that contribute to apathy is of 
clinical and theoretical importance. At present, no one has identified effective treatments 
for apathy (Drijgers, Aalten, Winogrodzka, Verhey, & Leentjens, 2009). This may be due, 
at least in part, to consideration of apathy as a single, undifferentiated phenomenon when, 
in fact, specific components may be differentially compromised. From this perspective, 
treatment of an initiation deficit may not benefit an individual with impaired motivation. 
A crucial step toward improving management of apathy, thus, may involve improving 
understanding of the mechanisms that contribute to apathy. According to a GDB model, 
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at least three core processes—initiation, planning, and motivation—must be functional to 
translate an idea into a goal-obtaining action (Brown & Pluck, 2000). Impaired initiation 
limits spontaneous action and results from difficulty activating cognitive and motor 
functions to initiate an act or thought. Plans of action often consist of multiple mental 
steps, and compromised planning may limit the ability to manipulate the components of a 
task mentally in order to execute an action. Impaired motivation compromises the ability 
to process the internal and external determinants that augment the rewarding value or 
help avoid the negative consequences associated with the intention to act (Levy & Dubois, 
2006). The present study used the GDB model to demonstrate differentiated deficits in 
these three components of apathy in bvFTD. 
An international task force proposed criteria for the clinical diagnosis of apathy in 
neurodegenerative conditions, drawing a distinction between behavioral, cognitive, and 
emotional domains (Robert et al., 2009). These correspond in part to the initiation, 
planning, and motivation components of apathy suggested by the GDB model. One of the 
primary obstacles to advancing knowledge in this area has been the absence of a 
quantitative method that directly measures specific mechanisms contributing to apathy. 
Although several global apathy-assessment tools exist for the cognitively impaired 
population, there is a lack of agreement on the interpretability of the data from these 
measures (Clarke et al., 2011). This lack of consensus may be due in part to the fact that 
traditional instruments to ascertain apathy commonly use proxy report. This approach is 
subject to caregiver confounds such as burden and strain that may impact the evaluation. 
Indeed, we did find the ascertainment of apathy by proxy report was biased by caregiver 
stress. Caregiver distress scores and FxS scores were correlated (r = .47; p = .04), 
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suggesting that estimated symptom severity in bvFTD was likely biased by caregiver 
distress. 
Further, beyond confirming the presence of apathy, current instruments such as 
the NPI are ineffective in identifying different subtypes of apathy (Chow et al., 2009). 
One goal of the present study was to quantify components of GDB in apathetic 
participants in an objective manner, minimally confounded by proxy report. In a series of 
bvFTD patients with apathy, we identified individuals who demonstrated single deficits 
in each of the hypothesized components of GDB, providing some validation for this 
approach. Additional work is needed to examine these components in larger groups of 
participants with bvFTD and other neurodegenerative conditions. 
The failure to initiate behavior leads to a subtype of apathy such that an individual 
is unable to generate a signal significant enough to begin a response. The akinetic-mute 
state describes individuals who sit quietly in the same position all day without speaking, 
due to anterior cingulate damage (Mega & Cohenour, 1997). Abulia is the loss of 
initiative and spontaneous thought, and external stimulation is needed to start mental 
activity or speech (Quaranta, Marra, Rossi, Gainotti, & Masullo, 2012). The initiation 
condition of the PACT assesses this GDB component quantitatively by measuring the 
latency to initiate a movement in response to a visual signal. We found that some 
apathetic bvFTD individuals are significantly impaired only on this component of GDB. 
Moreover, this impairment was associated with anterior cingulate atrophy. 
Initiation difficulty is not the only basis for apathetic behavior. The ability to 
execute an action is also highly dependent on the cognitive processes needed to plan, 
organize, and carry out goals. Apathy related to “cognitive inertia” can result from 
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impairments in executive functions such as planning, working memory, and task-
switching (Burgess, 2000; Levy & DuBois, 2006). Apathy in AD has been related to 
difficulty performing several tasks interchangeably (Esposito et al., 2010). In PD, 
performance on standardized tests of planning was associated with severity of apathy 
(Weintraub et al., 2005). Poor planning was the most prevalent single component of 
apathy found to be impaired in our bvFTD sample. This is not surprising, given that a 
dysexecutive neuropsychological profile is a common finding in bvFTD (Rascovsky et al., 
2011). Moreover, we found that this subtype of apathy is associated with lateral 
prefrontal atrophy. Other work has associated executive difficulty in bvFTD with lateral 
prefrontal atrophy (Huey et al., 2009). 
Another component of GDB is motivation, that is, responsiveness to external and 
internal drives that may be positive or negative. Apathy may result from a lack of 
responsiveness to reward or risk, thereby making goal-selection difficult (Levy & Dubois, 
2006; Rosen et al., 2002; Schultz et al., 2000). Likewise, reduced ability to assess and 
interpret consequences of actions, whether positive or negative, can limit motivation 
(Zamboni et al., 2008). Patients with bvFTD typically have a greater desire for certain 
rewards such as money and social praise, but tend to show less sensitivity to negative 
consequences (Grossman et al., 2010; D. C. Perry, Sturm, Wood, Miller, & Kramer, 
2013). We found that patients performed faster on the reward condition (compared to the 
simple condition without incentive), suggesting they were motivated by a monetary 
incentive. Their performance pattern did not change, however, when we took away 
monetary units for not performing faster, thereby suggesting relative insensitivity to 
negative consequences. In our sample of bvFTD participants, we identified some 
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individuals with insensitivity to the motivational component of GDB, associated with 
OFC atrophy. Other work has associated limited motivation with ventral frontal atrophy 
in bvFTD (Grossman et al., 2010). 
Although each of the three components we assessed may contribute to GDB, 
clinical observations suggest that deficits in initiation, planning, and motivation may not 
be sequential, as some have hypothesized (Levy & Dubois, 2006). Instead, apathy may 
arise when any one of these three processes is impaired. For example, patients who have 
profound impairments in planning an action may be able to initiate an action and may be 
motivated to achieve a goal, but their planning impairments alone may make it difficult to 
engage in GDB. Our findings suggest that initiation, planning, and motivation processes 
are relatively independent and, when compromised, may each contribute to apathy. 
Additional work is needed to confirm these profiles in a longitudinal cohort. Nevertheless, 
we found several individuals who appeared to be impaired with multiple components of 
GDB. That is, some patients with initiation difficulty also had limitations in planning, 
motivation, or both. Although consideration may be given to the possibility that a deficit 
in initiation may also lead to additional difficulty in other GDB components, the 
observation of independent deficits in each GDB component makes this less likely. 
Compared to individuals displaying a multicomponent subtype of apathy, those with a 
single GDB deficit did not differ by age, disease duration, and MMSE (all p > .05). This 
outcome suggests that variations in apathetic profiles are not easily attributable to 
variability in the underlying disease process, but instead are related, at least in part, to 
anatomical distribution of disease. 
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Our findings need to be interpreted in light of several limitations. Our findings 
require confirmation in a larger sample of participants. We studied patients with relatively mild 
disease, and it would be valuable to extend assessment to more severely impaired patients. We 
studied bvFTD particularly because apathy is very common in this condition, these patients do 
not have motor limitations such as weakness or involuntary movements that can confound the 
quantitative assessment of reduced GDB, and there are no language or visuospatial deficits that 
can potentially limit the interpretation of impaired performance. Nevertheless, it would be 
important to investigate GDB in apathetic patients with other neurodegenerative conditions 
such as AD or PD who also display apathy. 
With these caveats in mind, we identified three components of GDB, using a 
novel computerized RT test that may show independently impaired results in apathetic 
patients with bvFTD. There appear to be at least three distinct sources of apathy, 
including a deficit in initiation, planning, or motivation, and these appear to depend in 
part on regions in the frontal lobe that support GDB. Impairment in any one or 
combination of these components—initiation, planning, or motivation—may emerge as 
apathy. 
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CHAPTER 4: THE NEURAL BASIS OF APATHY IN FRONTOTEMPORAL 
DEGENERATION: A LONGITUDINAL STUDY1 
Specific Aims 
Apathy, a reduction in GDB (Levy & Dubois, 2006), affects 90% of people with 
bvFTD (Diehl-Schmid et al., 2006), a common cause of early onset ND (Vilalta-Franch 
et al., 2013). The cognitive and neural impairments associated with apathy make it 
difficult to initiate, plan, and motivate activities toward a specific goal, such as dressing 
or bathing. These impairments are associated with significant decline in functional ability, 
caregiver burden, and increased cost of care due to early institutionalization (Butterfield 
et al., 2010; Lechowski et al., 2009; Massimo et al., 2009; Okura et al., 2011). Caregivers 
struggle to provide care without hope of relief because current treatments are ineffective 
(Mizrahi & Starkstein, 2007). In this interdisciplinary research training grant, I propose 
innovative methods to advance understanding of the longitudinal course of apathy, a 
clinical manifestation of brain pathology in persons with bvFTD. My long-term goal is to 
design tailored interventions targeting reduction and management of apathy and the poor-
health outcomes that accrue to affected individuals and their caregivers. This work will 
also serve as a training venue to help me attain my professional goal to become an 
independent researcher by developing expertise with new measures of moderators 
(environmental factors and genetics), as well as new statistical (longitudinal analysis) and 
imaging techniques (diffusion-tensor imaging). 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 This chapter was submitted as a National Research Service Award for Individual Post-Doctoral 
Fellows (F32). It appears here as it does in the submitted application. 
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In my dissertation work, funded by an Individual Predoctoral National Research 
Service Award (F31NR013306), I used empirical methods to identify three subtypes of 
apathy in bvFTD that interfere with GDB: impairments in initiation, planning, and 
motivation. Each of these deficits was associated with selective disruption of a large-
scale neuroanatomic network underlying GDB. Specifically, initiation subtype was 
related to atrophy in ACC, the planning subtype was related to atrophy in dlPFC, and the 
motivation subtype was related to atrophy in OFC. My preliminary longitudinal data 
revealed that decline is restricted to the subtype of initial impairment and does not 
generalize to the other subtypes. These distinct types of apathy may benefit from 
interventions tailored to mediate each compromised mechanism, but I must first 
understand the natural history of these impairments and the biological and environmental 
factors that influence the rate of decline. Cognitive-reserve theory is a framework for 
understanding these brain–behavior relationships. Using cognitive-reserve theory, I posit 
that environmental factors (education, occupation, and leisure activities) are related to 
neural connectivity and cognitive strategies that support brain functioning in the face of 
ND, and thereby play a moderating role in the rate of longitudinal decline (Steffener & 
Stern, 2012). Biological factors that impact longitudinal decline include focal changes in 
grey matter and associated white matter tracts and genetic factors such as Apolipoprotein 
E (ApoE) and tau haplotype (Morley et al., 2012a; Van Gerven, Van Boxtel, Ausems, 
Bekers, & Jolles, 2012; Whitwell et al., 2008). I will examine both types of factors in this 
study. 
The identification of factors that moderate the clinical expression of disease, in 
this case apathy, is an important consideration for identifying persons “at risk” for more 
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rapid decline and optimizing interventions for all persons with apathy associated with ND. 
This research training proposal is a longitudinal investigation of impaired GDB using 
resources from an ongoing program project, “Cognitive and Neural Impairment in 
Frontotemporal Dementia” (P01-AG17586), which includes longitudinal clinical, 
neuropsychological, neuroimaging, and genetic data. 
The goals of this research proposal will be achieved through three aims: 
Aim 1. Examine longitudinal changes in subtypes of apathy in bvFTD compared 
to NC. 
H1: Based on preliminary longitudinal data, I hypothesize that apathy will worsen 
in bvFTD, and that decline will be restricted to the subtype of initial 
impairment. 
Aim 2. Determine the effect of environmental factors (education, occupation, and 
leisure activities) and genetic factors (ApoE status and tau haplotype) as moderators of 
annualized rate of change in apathy subtypes. 
H1: I hypothesize slowed annualized worsening in apathy in bvFTD individuals 
with higher education and occupational attainment and greater leisure 
activities. 
H2: A more rapid rate of worsening in apathy will be associated with the presence 
of ApoE e4 allele and tau H1H1 haplotype in bvFTD. 
Aim 3. Relate changes in apathy subtypes in bvFTD to annualized grey matter 
thinning and reduced FA on DT imaging studies of white matter; and I will explore the 
impact of moderating environmental and genetic factors on rates of grey matter and white 
matter change in anatomic structures related to each apathy subtype. 
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H1: Change in each bvFTD apathy subtype will be related to progressive grey 
matter thinning of specific frontal brain regions and to reduction in FA in 
related white matter tracts. 
The results from this proposed research will improve understanding of apathy by 
providing insights into mechanisms of longitudinal decline and neural compensation. 
Optimized interventions for apathy can be designed based on an understanding of these 
mechanisms. For example, knowledge of the progression of apathy will give direction for 
designing tailored interventions that target problems with initiation, planning, and 
motivation, and the optimal timing of their implementation. This work will also allow us 
to assess the effectiveness of these interventions based on a comparison with the natural 
trajectory of change in bvFTD-related apathy. This work supports the National Institute 
of Nursing Research strategic plan and will further my career goal to become an 
independent researcher. 
Significance 
Apathy is extraordinarily common in ND, contributing to poor patient and 
caregiver outcomes. Deficits observed in apathetic persons, such as poor planning, poor 
motivation, and inability to initiate even the simplest self-care activities, contribute to 
deteriorating function and greatly reduced quality of life (Pedersen, Alves, et al., 2009). 
Apathy is also associated with other undesirable features, such as poor insight and 
impaired cognitive performance (Chase, 2011; Ishii et al., 2009; Pedersen, Alves, et al., 
2009; Pluck & Brown, 2002). These features have strong implications for noncompliance 
with therapeutic interventions and further exacerbate disability (Chow, Pio, & Rockwood, 
2011). Furthermore, apathy appears to be an independent predictor of earlier risk for 
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mortality (Brown & Pluck, 2000; Holtta et al., 2012; Vilalta-Franch et al., 2013). The 
societal costs associated with caring for people with ND are enormous. The annual global 
burden cost of dementia is estimated at $315 billion (Dartigues, 2009). Long-term care is 
a significant driver of costs and rates of institutionalization are higher in apathetic 
persons because of the significant strain placed on caregivers (Bakker et al., 2012). 
Caring for a person with apathy is extremely challenging. The physical and 
emotional demands associated with the need to perform the simplest activities for those 
with apathy are profound, and high levels of depression, burden, and stress are reported 
in caregivers of apathetic persons (Chio et al., 2010; Massimo et al., 2009). Caregivers 
misinterpret apathy as a sign of volitional opposition and poor cooperation (Bakker et al., 
2012; Massimo, Evans, et al., 2013), leading to dissatisfaction with caregiving (Landes et 
al., 2001). Thus, it is important to optimize management of apathy. Additionally, 
caregivers often want to know what to expect behaviorally from the patient over the 
course of their disease (Chow et al., 2012). Insight into the trajectory of apathetic 
behavior is important to prepare caregivers for the changes in the affected person. 
Findings from this study will be used to inform caregivers about what to anticipate as the 
disease progresses. Prognostic information can be used as a decision aid to determine 
resources for support. 
Currently there are no effective treatments for apathy because of a poor 
understanding of the mechanisms underlying this condition. Treatments for apathy can 
best be developed in a context where behavioral and anatomic substrates of apathy are 
understood. My preliminary dissertation work shows that there are distinct subtypes of 
apathy associated with distinct anatomic substrates (Massimo, Evans, Morgan, Powers, 
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Grossman, 2012; Massimo, Morgan et al., 2012). An approach accepted for a wide 
variety of circumstances to manage apathy, thus, appears to be inappropriate, and tailored 
interventions focusing on a specific apathy subtype are more likely to be successful. 
Researchers assume that apathy worsens over time (Chow et al., 2012; Turro-Garriga et 
al., 2009), yet do not know if these distinct apathy subtypes persist or change 
longitudinally. Knowledge of the natural history of apathy is essential in the development 
of treatment trials for apathy. This knowledge will contribute critical information to the 
design of interventions and inform selection of end-points in treatment trials. In the 
proposed work, I will examine how persons with apathy worsen over time (Aim 1) and 
identify the influence of environmental, genetic (Aim 2) and anatomic (Aim 3) factors on 
the rate of change in apathetic persons. The proposed work will fill a crucial gap and will 
be used to develop treatment strategies and evaluate the effectiveness of tailored 
interventions. 
Conceptual framework. Disturbances of GDB in ND represent a significant 
problem that is understudied. In neuroscience, GDB is used to operationalize a broad spectrum 
of purposeful actions and their determinants (Brown & Pluck, 2000). GDB is related to the 
belief that when action a is taken, x may be obtained as a result. The GDB model has been 
proposed to improve understanding of the mechanisms that contribute to the loss of self-
initiated action (Levy & Dubois, 2006); a behavior referred to as “apathy.” According to the 
model, three processes—initiation, planning, and motivation—influence the intention to act. 
Apathy arises when any one of these three processes is impaired (Massimo, Evans et al. 2012; 
Massimo, Morgan et al., 2012). 
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These three GDB processes map onto three distinct brain regions that work 
together in a large-scale neural network associated with apathy. In particular, three 
functional neuroanatomic loops underlying GDB in the frontal area (anterior cingulate 
circuit, dorsolateral prefrontal circuit, orbitofrontal circuit) appear to capture the 
information from internal and external environments needed for GDBs and possible 
actions to be performed. Each circuit is functionally separate in supporting initiation, 
planning, and motivation, but interacts with the others to mediate overall GDB. Previous 
imaging studies in persons without apathy, and my dissertation data on apathetic persons, 
suggest that poor initiation is related to ACC disease, (Kotchoubey et al., 2003; Reijnders 
et al., 2010), poor planning is related to disease in dlPFC (Kaller et al., 2011; Unterrainer, 
Rahm, Kaller, Leonhart, et al., 2004; van den Heuvel et al., 2005), and reduced 
motivation is related to disease in OFC (Diekhof et al., 2011; Sescousse et al., 2010). A 
specific process of GDB suffers when one of these frontal areas is compromised, 
resulting in apathetic behavior. The proposed research will extend my cross-sectional 
dissertation data. First, I will study longitudinal changes in behavior and neuroanatomy 
following an impairment of each process of GDB. Second, I will examine the influence 
of environmental, genetic, and anatomic factors. A more complete understanding of 
apathy will lead to the development of treatments for persons with specific subtypes of 
apathy. 
Few studies have examined longitudinal decline in bvFTD, a disorder of social 
comportment and executive dysfunction related to frontal and temporal degeneration. 
Researchers previously reported that neuropsychological impairments in bvFTD remain 
distinct over the duration of illness rather than converging in a common undifferentiated 
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state (Libon et al., 2009). This outcome suggests the brain is highly organized around 
specific cognitive functions involving large-scale neural networks. These neural networks 
allow individuals to implement compensatory cognitive strategies, thereby maintaining 
relatively distinct patterns of impairment well into the disease course (Gigi, Babai, 
Penker, Hendler, & Korczyn, 2010). Compensatory brain-reserve mechanisms have been 
assessed in only two studies of bvFTD, revealing that reserve mechanisms may be 
moderated by factors such as education, occupation, and leisure activities (Borroni et al., 
2009; Y. Liu et al., 2012; Premi et al., 2012; Stern, 2006). Moreover, genetic factors such 
as ApoE status and tau haplotype may influence the presence of neuropsychiatric 
symptoms (Panza et al., 2012), including apathy (D’Onofrio et al., 2011; Monastero et al., 
2006) and genetic markers such as the presence of the e4 allele have been associated with 
faster decline in ND, although this has not been assessed in bvFTD. This research 
proposes to examine the influence of environmental factors and genetics on a common 
neuropsychiatric syndrome in well-characterized persons with bvFTD to gain a better 
understanding of reserve mechanisms and their relationship to behavioral functions such 
as apathy to determine who may be “at risk” for faster decline. Finally, brain atrophy is 
progressive in a small number of bvFTD studies, (Frings et al., 2012; Gordon et al., 2010; 
Whitwell et al., 2008) but the neuroanatomic basis for longitudinal worsening of apathy 
has not been examined. 
Preliminary studies. 
Although several apathy assessment tools exist for the cognitively impaired 
population, current instruments such as the NPI are ineffective in identifying subtypes of 
apathy (Chow et al., 2009) and may be confounded by caregiver stress (Boyer, Novella, 
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Morrone, Jolly, & Blanchard, 2004). Moreover, caregiver-completed surveys do not 
assess apathy directly through patient performance. Therefore, as part of my dissertation 
work, I developed the PACT, a novel behavioral instrument, based on the GDB model, a 
review of experimental paradigms in the scientific literature and clinical observations 
(Elliott et al. 2010; Jenkins et al., 2000; Ruh et al., 2010). PACT is used to capture 
subtypes of apathy based on impairments in GDB (initiation, planning, and motivation). 
A trial begins with a start key depressed. In response to a signal, RT1 is measured when a 
participant lifts their finger from the start key; RT2 is the time needed to depress the 
target key. Total latency is the sum of RT1 and RT2. Initiation is assessed by measuring 
RT1 to a single visual stimulus. To measure the planning component of GDB, two levels 
of task difficulty are assessed. To assess motivation, the “simple” planning level is 
repeated with a monetary incentive (reward and penalty conditions) using a point system 
of “monetary units.” Three scores (see Table 13) are generated from these times in the 
conditions described below for the proposed analysis. Below is a detailed description of 
the PACT. 
Table 13 
Scores Generated from the PACT 
Score Measure 
Initiation Reaction Time 1 in initiation condition 
Planning Total latency in “complex” planning level minus Total latency in “simple” planning 
level 
Motivation Total latency in reward or penalty condition minus Total latency in “simple” level from 
Planning condition 
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Preliminary Study 1. My dissertation work examined performance on the PACT 
for 19 persons with bvFTD (see Table 13). Participants with an initiation impairment 
(N = 5/19) demonstrated significantly slowed time to initiate a response (RT1). Imaging 
data showed atrophy in the ACC in this group (see Figure 4, Panel B blue). The planning 
impaired group (N = 8/19) had significantly slowed latencies and made errors on the 
complex measure of the PACT. Imaging data showed dlPFC atrophy in this group (see 
Figure 4, Panel A green). Participants in the third group with impaired motivation 
(N = 6/19) were not motivated to perform faster in response to the penalty condition in 
the PACT. This group showed significant atrophy in OFC (see Figure 4, Panel A yellow). 
 
Figure 4. Significant regressions of apathy subtypes using PACT measures. 
Blue = initiation (anterior cingulate cortex); Green = planning (dorsolateral prefrontal 
cortex); Yellow = motivation (orbitalfrontal cortex). 
Preliminary Study 2. I collected longitudinal data (mean follow up = 12months) 
in 7 bvFTD participants (see Figure 5). Two participants had initiation subtype at Time 1. 
Both participants showed more slowing on the initiation measure at Time 2 (slowed by an 
average of 162.71msec), but not on the planning or motivation measure (see Figure 5, 
Panel A). Three participants met criteria for the planning subtype at Time 1. Times 
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slowed for two of three participants (by an average of 108.60msec) on the planning 
measure, but not on the initiation or motivation measure (see Figure 5, Panel B). Two 
participants met criteria for the motivation subtype at Time 1. At Time 2, only one 
participant had additional slowing (555.15msec) on the motivation measure of the PACT. 
There were no additional worsening on initiation or planning measures (see Figure 5, 
Panel C). In sum, five of seven participants showed worsening that was restricted to the 
domain of initial impairment. Two of the seven participants mentioned above did not 
show slowing at Time 2. It is possible that these participants have cognitive reserve that 
slows the rate of apathy worsening, and I will examine this factor in the proposed study. 
 
Figure 5. Longitudinal worsening in apathy subtypes on PACT measures. 
 
Preliminary Study 3. To explore the effect of cognitive reserve on the 
longitudinal trajectory of bvFTD, I performed a retrospective chart review of autopsy 
confirmed bvFTD (n = 63). I found that environmental factors like higher occupational 
attainment, a proxy for cognitive reserve, were associated with longer survival time in 
bvFTD (F = 6.31, p = .0006) (Massimo et al., 2013). In the proposed study, I will 
91 
	  
examine the moderating effect of cognitive reserve on annualized rate of change in the 
profile of apathy subtypes. 
Research Strategy 
A longitudinal case-control research design will be employed to conduct this 
study. I chose to compare normal and diseased populations (bvFTD) to elucidate 
mechanisms contributing to apathy subtypes. I focus particularly on bvFTD because 
apathy is very common in this condition and my dissertation data demonstrated the 
presence of each apathy subtype in bvFTD. These individuals do not have physical 
limitations that can confound the quantitative assessment of reduced GDB, and have no 
language or visuospatial deficits that can potentially limit the interpretation of bvFTD 
patient performance during the study. I have the opportunity to integrate my aims and 
instruments to collect prospective data on NC and bvFTD participants, as they are newly 
enrolled in the cosponsor’s ongoing study, “Cognitive and Neural Impairment in 
Frontotemporal Dementia” (P01-AG017586, PI: Virginia Lee, PhD; Clinical Core 
Leader: Murray Grossman, MD). The purpose of Dr. Grossman’s longitudinal study is to 
collect neuropsychological, neuroimaging, cerebrospinal fluid and genetic data to better 
understand the neural basis of impairments in this population, and relate these data to 
findings at autopsy. Potential participants are recruited from Dr. Grossman’s FTD clinic 
(University of Pennsylvania Center for Frontotemporal Degeneration) in Philadelphia, 
PA. Consented participants are assessed at baseline and then 6–12 months following 
baseline (see Table 14). Qualifying individuals are invited to enroll. All participants meet 
enrollment criteria listed in Table 15. 
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Table 14 
Schedule of Data Collection 
Time 1 
initial visit 
(Day 1–2) 
Clinical diagnosis and demographics 
Mini-Mental State Exam 
Neuropsychiatric Inventory 
Geriatric Depression Scale Short Form 
Genetic Data 
Neuroimaging 
Philadelphia Apathy Computerized Test 
 Lifetime of Experiences Questionnaire 
Time 2 
follow-up visit 
(6–12 months after 
initial visit) 
Mini-Mental State Exam 
Neuropsychiatric Inventory 
Geriatric Depression Scale Short Form 
Neuroimaging 
Philadelphia Apathy Computerized Test 
 
I will have full access to these data, including neuroimaging and genetic data, for 
my own analyses. The proposed study extends the parent study by prospectively 
collecting the PACT and Lifetime of Experiences Questionnaire (LEQ) for eligible 
participants coinciding with the first two data-collection points (Times 1 and 2). Table 14 
explicates the data-collection schedule for each participant; measures added for the 
proposed study are bolded. Currently 54 participants with bvFTD are being followed 
longitudinally and we have successfully collected full sets of multimodal data 
(neuropsychology, DNA, grey matter imaging, and white matter imaging) for 43 of these. 
The setting is a reliable source of well-characterized clinical patients because four new 
bvFTD patients are diagnosed each month and > 80% of these patients agree to 
participate in Dr. Grossman’s research program (see Table 15, Enrollment Criteria for 
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Proposed Study). NCs are recruited from the surrounding community and screened prior 
to entry in the parent study. 
Table 15 
Enrollment Criteria for the Proposed Study 
Inclusion Exclusion 
Individuals diagnosed with bvFTD (Rascovsky 
et al., 2011) or NC 
Persons with other neurologic conditions such as stroke 
or hydrocephalus, primary psychiatric disorder such as 
depression of psychosis, or systemic illness that could 
interfere with cognitive functioning. 
Mild impairment (measured by Mini-Mental 
State Exam ≥ 20) at initial visit 
Mini-Mental State Exam ≤ 19 to exclude moderate or 
severe dementia to minimize confounding factors 
related to severe cognitive impairment. 
Participants who are not depressed as 
determined by Geriatric Depression Scale Short 
Form score of ≤5 at initial visit. 
Individuals with depression (Geriatric Depression 
Scale-Short Form score > 5) are excluded because 
depression is confused with apathy and can confound 
interpretation of the data. I will exclude participants in 
the rare event that participants become depressed 
during follow up. 
Modest doses of selective serotonin reuptake 
inhibitors or antipsychotic medication may be 
needed for clinical management, and thus are 
allowed. Moreover, a stable dose (no change 
during follow-up study period) is necessary to 
minimize potential confounding effects because 
these medications can contribute to apathy 
(Benoit et al., 2008). 
Participants taking regular doses of benzodiazepines 
and other soporific medications will be excluded 
because of their sedative effects. 
A reliable caregiver who has frequent contact 
with the participant (> 3 times/week for ≥ 1 
hour). 
Participants who do not have caregiver contact. 
Frequent contact with patient is needed to accurately 
rate the patient’s behavior, because patients with 
bvFTD often have poor insight into their own deficits 
(Massimo, Libon et al., 2013). 
Speak and understand English to complete the 
questionnaires. 
Insufficient English to complete questionnaires. 
 
In Aim 1, a standard apathy scale from the NPI will be administered to identify 
participants with apathy. The PACT will be administered to ascertain initiation, planning, 
and motivation subtypes of apathy in bvFTD. The PACT will be collected again 6–12 
months after the initial visit to examine longitudinal change. I will specifically monitor 
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whether participants with all subtypes of apathy, regardless of their initial presentation, 
maintain their distinct subtype profile of apathy longitudinally or accumulate additional 
subtype features to converge on a single apathy phenotype over time. 
In Aim 2, potential moderating environmental factors (education, occupation, and 
leisure activities) and genetic factors (ApoE status and tau haplotype) will be related to 
changes in apathy subtypes over time. From the perspective of the model of longitudinal 
change known as “cognitive reserve,” factors such as education, occupation, and leisure 
activities may moderate the rate of longitudinal decline (Bartres-Faz & Arenaza-Urquijo, 
2011). Thus, I propose to monitor the ways these environmental and genetic factors 
moderate the rates of clinical progression (Stern, 2002). Importantly, this knowledge will 
provide insight into potential responses of participants to planned cognitive interventions 
for apathy (Simon, Yokomizo, & Bottino, 2012). 
In Aim 3, MRI obtained at initial and follow-up assessments in apathetic 
participants will be compared to NC, and regression analyses will relate apathy subtype 
scores (see Table 13) to cortical thinning and FA of white matter tractography. Biological 
factors such as grey matter volume and white matter tractography must be considered to 
understand the neuroanatomic basis of change in apathy subtypes. During longitudinal 
monitoring of apathy, progression restricted to a specific subtype should continue to 
involve primarily a specific neuroanatomic circuit; by comparison, progression involving 
additional apathy subtypes may incorporate additional disease involving other brain 
regions associated with apathy and/or white matter tracts. I will also explore whether 
environmental and genetic factors impact longitudinal MRI changes in areas related to 
apathy subtypes. 
95 
	  
Instrumentation for Aim 1: Examine longitudinal changes in subtypes of 
apathy. 
The PACT is a novel, quantitatively rigorous computerized RT test designed to 
quantify each GDB process. In my preliminary dissertation data, the PACT is able to 
identify apathy subtypes according to distinct behavioral response patterns (Massimo, 
Evans et al., 2012; Massimo, Morgan et al., 2012). In all conditions, a trial begins when 
the participant depresses a computer “start” key with one finger. The PACT measures RT 
to lift this finger from the start key in response to a signal (RT1) and then RT to depress 
the target key (RT2). 
Initiation refers to one’s ability to self-generate or activate actions (Levy & 
Dubois, 2006). In the simplest condition designed to measure initiation, the participant 
begins a trial by depressing the start key, then a central stimulus on the computer screen 
appears. A fixed central target key must be depressed in response to this stimulus; the 
stimulus occurs on average 1,250msec (range 500–2000msec) after depressing the start 
key. Initiation is assessed by measuring RT1. 
Planning refers to the ability to elaborate plans of action (Levy & Dubois, 2006). 
In the second condition, designed to assess the planning process of GDB, two levels of 
task difficulty are assessed. In the first, “simple” level, after depressing the start key, 
participants are signaled by randomly-ordered lateralized visual stimuli to press a left or 
right target key (stimulus appears on the left, then go left; stimulus appears on right, then 
go right). In the second, “complex” level, one of two lateralized keys is pressed 
contingent on the combination of patterns in a central visual stimulus (stimulus appears 
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on the left, then go left; stimulus appears on right, then go right). Planning is assessed by 
measuring the RT difference between these two levels of difficulty. 
Motivation refers to the ability to associate affective signals (positive or negative) 
with value in order to perform actions (Levy & Dubois, 2006). In the third condition 
designed to assess motivation, the “simple” level from the planning condition is repeated 
with an explicit monetary incentive using a point system (monetary units) to reward 
participants for responding correctly and more rapidly. Participants receive feedback 
about their response speed after each trial on the computer screen. I also assess the 
sensitivity to negative consequence by having a “penalty” condition, where participants 
are given monetary units at the beginning of each task, and monetary units are taken 
away if they do not respond correctly and more rapidly. (Unbeknownst to participants, all 
receive the same final amount for participation by adjusting the dollar value of a 
monetary unit.) 
I obtain 48 trials during each condition. A practice block precedes each 
experimental condition where participants get instructions on the task and 12 practice 
trials. The PACT measures RT1, RT2, total latency (RT1 + RT2) and errors. In our 
experience, the PACT takes approximately 45 minutes to complete. 
Instrumentation for Aim 2: Determine the effect of environmental factors 
(education, occupation, and leisure activities) and genetic factors (ApoE status and 
tau haplotype) as moderators of annualized rate of change in the profile of apathy 
subtypes in bvFTD. 
Environmental factors. The LEQ (Bartres-Faz & Arenaza-Urquijo, 2011) is a 
reliable and valid instrument that assesses cognitive lifestyle, a proxy for cognitive 
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reserve. The LEQ will be obtained by interviewing a knowledgeable informant for 
educational, occupational, and leisure activities that are protective against cognitive 
decline. The LEQ consists of 42 items constructed around two dimensions: three life 
stages (young, mid, and late adulthood) and specific versus nonspecific mental activity in 
each stage. Scores are calculated for each stage and then summed for a total LEQ score. 
Higher scores indicate higher lifetime mental activity. The LEQ has an overall internal 
consistency of .66 and test–retest reliability of .98, and it discriminates between older 
adults with high and low mental-activity levels. Healthy older adults with higher LEQ 
scores have shown less cognitive decline over 18 months than those with low scores, 
independent of covariates (Bartres-Faz & Arenaza-Urquijo, 2011). 
Genetic factors. DNA is extracted from frozen blood using a previously reported 
procedure (Van Deerlin et al., 2010). DNA samples will be evaluated for purity by 
spectrophotometric analysis (NanoDrop) and for degradation by 1% agarose gel 
electrophoresis (Invitrogen). Genetic analysis for bvFTD includes sequence analysis of 
ApoE genotype and tau haplotype. ApoE genotyping will be performed by Polymerase 
Chain Reaction-Restriction Fragment Length Polymorphism. Tau haplotypes will be 
determined by either DNA sequence analysis or by Polymerase Chain Reaction-
Restriction Fragment Length Polymorphism of Exon 9 using the following intronic 
primers: forward 5’acctgcctaacccagtggtg-3’ and reverse 5’gaggggactggggtgttatg- 3’. The 
amplified fragment will be digested with HpaII and HpyCH4IV and the resulting 
fragments analyzed by agarose gel electrophoresis to determine the haplotype based on 
three known polymorphisms of Exon 9 that segregate with the known major haplotypes. 
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Instrumentation for Aim 3: Relate changes in apathy subtypes in bvFTD to 
annualized grey matter thinning and reduced FA on DT imaging studies of white 
matter tractography. 
Volumetric MRI. T1-weighted MRI scans will be collected using a research-
dedicated Siemens Trio 3.0T scanner with 1-mm slice thickness, in-plane resolution 
= .9766 x .9766, and a 195 x 256 matrix using an magnetization-prepared 180 degrees 
radio-frequency pulses and rapid gradient-echo (MPRAGE) protocol (TR = 1,620ms, TE 
= 3ms, flip angle = 15°). 
Diffusion weighted image (DWI). DWI images are collected using the following 
parameters: FOV = 240mm; matrix size = 128 x 128; number of slices = 70; imaging 
resolution = 1.9 x 1.9 x 2 mm; TR = 8,000ms; TE = 82ms; fat saturation. In total, 34 
volumes will be acquired per subject, four volumes without diffusion weighting (b = 0 
s/mm2) interleaved within 30 volumes with diffusion weighting (b = 1,000s/mm2) along 
30 noncollinear directions. 
Analyses. 
Analyses Aim 1: Examine longitudinal changes in subtypes of apathy. The 
overall sample will be described demographically and according to continuous measures of the 
PACT using means, standard deviations, median, and interquartile ranges. Additionally the 
sample will be described according to the apathetic subtype of initiation, planning, and 
motivation (see criteria below) using means, standard deviations, and z-scores. I established the 
criteria shown in Table 16 to partition participants into subtypes using PACT observations 
(Elliott et al. 2010; Jenkins et al., 2000; Ruh et al., 2010). 
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Table 16 
Criteria for Apathy Subtypes 
Subtype Criteria 
Initiation Significantly slow RT1 in initiation condition; does not have slowed latencies for 
“complex” level of planning condition; able to improve performance on the “simple” 
planning level in response to “reward” or “penalty.” 
Planning  Significantly greater slowing on the “complex” planning level compared to the “simple” 
planning level; does not have slowed initiation for all conditions; able to improve 
performance on the “simple” planning level in response to “reward” or “penalty.” 
Motivation Fails to respond to “reward” or “penalty” motivators in “simple” level of planning 
condition; does not have slowed initiation for all conditions; does not have slowed 
latencies for “complex” level of planning condition. 
 
Individual z-scores will be used to define subtypes. These will be based on the 
entire patient population. Participants will be designated as a specific subtype if the 
z-score is > 1.96 for one condition, but within the range of the remainder of the 
population (i.e., z-score 1.96) for the remainder of the conditions. I will use a linear 
mixed-effects model (Laird & Ware, 1982) to assess longitudinal change in each subtype. 
Linear mixed-effects models account for within-subject correlations over time and 
accommodate both variable length of follow-up for different subjects and variation in the 
interval between assessments. In the analysis, the intercept and regression coefficients for 
the follow-up time will be treated as random effects, such that each individual would 
have a unique intercept and regression coefficient for the follow-up time. Population 
mean coefficients for the follow-up time will be obtained by averaging the participants’ 
specific regression coefficients for follow-up time. The population mean regression 
coefficient for the follow-up time estimates the annual change in PACT scores over time 
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and accounts for differences in baseline PACT scores. I will also confirm subtype 
worsening relative to NC. 
Analyses Aim 2: Determine the effect of environmental factors (education, 
occupational attainment, and leisure activities) and genetic factors (ApoE status and 
tau haplotype) as modulators of annualized rate of change in the profile of apathy 
subtypes in bvFTD. Environmental factors such as education, occupation, and leisure 
activities data will be scored according to the LEQ, as described above. The patient group will 
be dichotomized based on the following genotypes: (a) ApoE e4 carrier versus not; (b) 
microtubule-associated protein tau genotype H1/H1 versus not. Linear mixed-effects models 
will be used to test for associations between environmental factors, different genotypes and 
changes in apathy subtypes. 
Analyses Aim 3: Relate changes in apathy subtypes in bvFTD to annualized 
grey matter thinning and reduced FA on DT imaging studies of white matter 
tractography. 
Volumetric MRI. High-resolution volumetric (1mm3) images will be segmented 
and normalized to a common space using Pipedream and ANTs (Avants, Tustison, Song, 
et al., 2011; Avants et al., 2008), as previously reported. Briefly, this procedure provides 
the newest ideas and most current features (Harris, Adams, Zubatsky, & White, 2011): 
unbiased diffeomorphic and symmetric registration of MRI volumes into local template 
space. MRI volumes are then segmented into three tissue classes using probabilistic 
information and template priors (Avants, Tustison, Wu, et al., 2011) and from these 
images I will compute grey matter density and cortical thickness (Das et al., 2009). I will 
use the multiple-regression module in SPM8 to identify the relationship between 
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performance on each PACT score (see Table 13) and cortical thinning. To constrain the 
interpretation of the regression analysis to areas of known disease in bvFTD, I will use an 
atrophy mask generated from a t-test contrast of all apathetic bvFTD participants relative 
to NC. I will also evaluate atrophy in each apathy subtype defined according to 
behavioral performance on the PACT. I will evaluate longitudinal change in grey matter 
by generating a single volume reflecting longitudinal change (Time 2 - Time 1/months), 
and compare this to longitudinal change in NC. The regression module in SPM8 will be 
used to relate longitudinal imaging change to change in PACT scores. To determine the 
relative contribution to the variance of environmental and genetics factors, I will also 
perform a stepwise multiple-regression analysis. 
DTI. DWI images will be preprocessed using ANTs (Avants, Tustison, Song, et 
al., 2011) and Camino (J. Perry, 2002). Motion and distortion artifacts will be removed 
by affine coregistration of each DWI to the unweighted (b = 0) image in the diffusion 
imaging sequence. DT will be computed using a linear least squares algorithm 
implemented in Camino. The distortion between the participant’s T1 and DT images will 
be corrected by registering FA in the DT image to the T1 image. The DT image will be 
warped to template space by applying intrasubject (FA - > T1) and intersubject (T1 -
 > template) warps. A general linear-model module in SPM8 will be used to compare FA 
in bvFTD to NC. I will calculate mean FA in each apathy subtype defined by behavioral 
performance (see Section B.7.1). I will also use logistic regression to evaluate the 
relationship between apathy subtypes and FA. I will evaluate longitudinal change in FA 
by generating a single volume reflecting longitudinal change (Time 2 - Time 1/months). 
The regression module in SPM8 will be used to relate longitudinal imaging change to 
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change in PACT scores. To determine the contribution of environmental and genetic 
factors, I will perform stepwise multiple-regression analysis. 
Power analyses. Sample-size estimates and power calculations are based on the 
minimum detectable slope (rate of decline) difference between two groups (e.g., NC and 
bvFTD) over time using a mixed-effect model, with an α = .05. I assume moderate 
correlations between repeated measures (r = .5) and one follow-up after baseline. Table 
17 lists sample size needed per group to detect a slope difference between two groups. 
With 16 participants per group, we will have 80% power to detect a slope difference of 
1.0 SD of an outcome measure (e.g., PACT scores). The detectable effect size (1.0 SD) is 
larger than what was observed (0.3 SD) in pilot data. However, the current study allows 
me to generate important pilot data for a larger scale study in the future. For the imaging 
studies, a minimum of 20 participants are required in each group to detect a 1mm 
(equivalent to 1 voxel) change at the p < .05 (corrected) level with a beta of 0.15 
(power = .85). The final sample size, accounting for a 10% attrition rate will be 44 
participants (NC and bvFTD). 
Table 17 
Sample Size to Detect Difference Between Two Groups 
SD diff β = 0.8 β = 0.9 
0.5 63 84 
0.75 28 37 
1.0 16 21 
1.5 7 9 
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Potential Challenges 
Interpretation and potential problems Aim 1. I predict that the profile of 
apathetic subtypes will be maintained over the course of the disease trajectory, (Libon et 
al., 2009), although additional deficits may accrue over a longer duration. If I see slowed 
RTs for more than one PACT measure in a subtype, I will look for additional evidence 
for generalized cognitive worsening using neuropsychological measures (collected by the 
cosponsor’s ongoing longitudinal study), as previously reported in my cross-sectional 
dissertation study, and covary PACT performance for these general cognitive deficits. 
There may not be worsening in a subtype, and this may be due to not enough time 
between Time 1 and Time 2. I will also assess cognitive reserve factors that may 
minimize or slow worsening (see Aim 2). 
Interpretation and potential problems Aim 2. I predict that the rate of change 
in apathy will be moderated by environmental and genetic factors. There may be too 
much variation in occupation and leisure activity so I may have to categorize these 
variables according to level of cognitive stimulation the activity provides, as previously 
reported (Foubert-Samier et al., 2012). I expect participants with e4 alleles and H1H1 
haplotypes will have faster rates of worsening in apathy than those without these genetic 
markers (Di Maria et al., 2010; Morley et al., 2012). If I do not detect an effect on the 
trajectory of apathy due to limited impact of genetics on apathy, I will look for additional 
evidence of moderating effects in other cognitive domains using longitudinal 
neuropsychological (collected under the cosponsor’s ongoing longitudinal study). I may 
also look at the influence of the number of e4 alleles on apathy worsening (additive 
model) rather than the proposed dominant method (e4 present or not). Rather than 
104 
	  
affecting the slope of decline, factors such as education and leisure activities may delay 
the point at which worsening begins; likewise, the presence of genetic risk factors may 
hasten the onset of worsening rather than steepen the slope. These alternatives can be 
assessed statistically. 
Interpretation and potential problems Aim 3. I predict that apathetic 
participants will have significant cortical thinning and loss of white matter integrity in the 
frontal lobe (Diekhof et al., 2011; Kaller et al., 2011; Kotchoubey et al., 2003; Reijnders 
et al., 2010; Sescousse et al., 2010; Unterrainer, Rahm, Kaller, Leonhart, et al., 2004). If 
unable to detect longitudinal change in the proposed imaging regression, I will obtain 
mean grey matter thickness values at Time 1 and Time 2 and compare with t-tests. I can 
also evaluate DTI using tract-specific analysis, which minimizes “crossing-fibers” and 
enables the analysis of individual white matter structures (Wimo, Jonsson, Bond, Prince, 
& Winblad, 2013). I will also evaluate whether white matter disease is related to grey 
matter disease or independent from grey matter disease by investigating the residuals of 
white matter atrophy in a linear regression that includes areas of grey matter atrophy as 
nuisance covariates, and vice versa. 
It is also possible that participants with long disease duration will have diffuse, 
nonspecific atrophy, and I propose to examine participants who are mild at initial visit. I 
will also evaluate whether disease duration and age contribute to group-level difference 
by including these as nuisance covariates. It may be difficult to obtain imaging in some 
participants because of time restriction, medical contraindication (e.g., claustrophobia 
and pacemakers) and participant preferences. If this is the case, participants will still be 
asked to participate in the PACT assessment and I will assess the dataset to ensure those 
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who are imaged are representative of the entire data set by performing t-tests to ensure 
there are no significant differences between those who are imaged and those who do not 
have imaging data. 
The MRI may not have been collected on the same day the PACT was 
administered; however all images will be collected within 6 months of the PACT. Given 
the rate of brain volume change in bvFTD, 6 months is a widely accepted timeframe 
(Whitwell et al., 2008). Despite these caveats, the results from this research will extend 
my dissertation work by providing an understanding of the trajectory of apathy as well as 
the identification of factors that moderate the progression of this devastating 
neuropsychiatric symptom. With this knowledge, tailored interventions that target 
problems with initiation, planning, and motivation can be appropriately designed and 
implemented. 
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CHAPTER 5: DISCUSSION 
Introduction 
Apathy, a reduction in GDB (Levy & Dubois, 2006), profoundly limits a person’s 
ability to engage in self-care activities. Apathy affects 90% of people with bvFTD (Diehl-
Schmid et al., 2006), a common cause of early onset ND. Researchers hypothesized that 
apathy emerges where there is dysfunction at the level of GDB (Levy & Dubois, 2006). 
Therefore, I proposed to use the GDB model to examine the brain-behavior relationships 
underlying apathy in bvFTD. Specifically, I conducted an empirical study that quantified 
difficulty with each component of GDB using a novel computerized RT test, examined 
the distinct prefrontal neuroanatomical substrates of these impairments in an apathetic 
bvFTD sample using regression, and related specific apathetic behaviors to grey matter 
atrophy and white matter integrity, quantified by MRI. This study used a novel RT test 
and neuroimaging to examine three dissociable behavioral and neuroanatomical 
components of GDB—initiation, planning, and motivation—in a sample of 20 apathetic 
adults with bvFTD and 17 normal older adults. Impairment in each of these components 
was associated with selective disruption of a large-scale neuroanatomic network 
underlying GDB. Specifically, impaired initiation was related to disease in the ACC, 
impaired planning was related to disease in the dlPFC and impaired motivation was 
related to disease in the OFC. Moreover, some participants with bvFTD were found to 
have specific subtypes of apathy, depending on the impaired GDB mechanism, whereas 
others had more global impairments. Together, these findings demonstrate that apathy is 
not simply a unitary phenomenon, but rather has multiple components related to 
impairments in GDB. In this chapter, I elucidate these findings: (a) how initiation, 
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planning, and motivation are supported by a large-scale neural network constituting the 
neuroanatomic basis for GDB, including distinct grey matter regions in the frontal lobe 
and related white matter projections, and (b) how, when compromised, impairments in 
these mechanisms contribute to apathy in bvFTD. This discussion concludes with 
implications for clinical practice and social neuroscience research. 
Summary and Discussion of Principal Findings 
GDB is supported by a large-scale neural network in distinct specific 
portions of the prefrontal cortex (AIM 1, see Chapter 2). The integration of three 
processes that influence the intention to act are central to the model of GDB is (Levy & 
Dubois, 2006). Initiation refers to one’s ability to self-generate or activate actions. 
Planning is the ability to elaborate plans of action. Motivation refers to the ability to 
associate affective signals (positive or negative) with value in order to perform actions. I 
found that apathetic bvFTD participants are impaired in one or more of these three 
processes. Further, impairments in these three GDB processes were associated with 
disease in three distinct frontal grey matter regions and in white matter projections 
between these regions and other brain areas. 
I found that difficulty in initiating a behavior is related to reduced grey matter in the 
ACC and white matter tracts including the cingulum (H1). Considerable published work has 
suggested that the ACC is important for initiating a behavior (Tekin & Cummings, 2002), 
and the ACC has previously been implicated in processes that influence action initiation 
in studies with healthy adults (Mulert et al., 2003). For example, fMRI studies have 
demonstrated the role of the ACC in processing “action”-related signals such as 
movement selection (e.g., simple finger tapping) and timing of movement initiation (e.g., 
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selecting the moment of when; Hoffstaedter, Grefkes, Caspers, et al., 2013; Hoffstaedter, 
Grefkes, Zilles, & Eickhoff, 2013). Additionally, the ACC is functionally linked to 
important motor systems such as premotor areas and the basal ganglia, suggesting a core 
network of brain structures, important for implementation of intentional motor control 
(Beckmann, Johansen-Berg, & Rushworth, 2009; Hoffstaedter, Grefkes, Caspers, et al., 
2013). 
The ACC is also implicated in initiation difficulty in those with frontal-lobe injury. 
For example, the akinetic mute state—a medical term describing patients who tend to sit 
quietly in the same position all day without speaking or talking—has been specifically 
related to ACC damage (Mega & Cohenour, 1997). The ACC has been well studied in 
dementia, and neuroimaging evaluations have linked the ACC region to apathy in various 
groups. Specifically, reduced grey matter density in the cingulate gyrus was associated 
with apathy in persons with bvFTD (Massimo et al., 2009; Zamboni et al., 2008) and PD 
(Reijnders et al., 2010). Previous DTI studies investigating white matter disease and 
apathy have shown associations among the three frontal areas important for GDB. That is, 
the cingulum has reciprocal connections between ACC and the medial orbitofrontal 
region that is important for motivation (Hahn et al., 2013; J. W. Kim et al., 2011; Ota et 
al., 2012). In healthy adults, ACC and dlPFC structures work in concert during complex 
tasks that require attentional control, and this is likely mediated through the cingulum 
(Silton et al., 2010). These prior findings provided support for the notion that disease in 
ACC and interruption of projections between ACC and other structures important for 
GDB may contribute to apathetic behavior, and were further supported in this study. 
109 
	  
I found that deficits in the planning component of GDB were associated with 
atrophy in the dlPFC and reduced FA in related white matter tracts, including SLF and 
frontal corona radiata (H2). fMRI studies of healthy adults suggested that the dlPFC 
supports planning and working memory (Di et al., 2013; Miller & Cohen, 2001). In 
addition, some studies demonstrated hemispheric specialization or differential effects of 
right and left dlPFC in planning tasks. For example, researchers thought the left dlPFC 
analyzes propositional information such as task parameters, whereas the right dlPFC 
manipulates and integrates information into a sequence (Huey et al., 2009; Ruh, Rahm, 
Unterrainer, Weiller, & Kaller, 2012). Thus, it is likely that patients who suffer from 
dysfunction in these circuits fail to elaborate, manipulate, and integrate important 
information needed for behavior that is goal directed. Studies have suggested a 
relationship between apathy and poor executive function in bvFTD (Eslinger et al., 2012; 
Zamboni et al., 2008). Eslinger and colleagues (2012) found caregiver apathy scores were 
significantly correlated with executive-function measures, suggesting that apathy 
emanates in part from difficulty manipulating and integrating elements of a plan to 
achieve a goal. Imaging studies of persons with FTD and AD have linked apathetic 
behavior to atrophy in dlPFC (Massimo et al., 2009; Zamboni et al., 2008). In addition, a 
previous study of persons with amnestic mild cognitive impairment revealed a 
relationship between reduced FA in the SLF and apathy (Cacciari et al., 2010). The SLF 
is a prominent white matter tract interconnecting the frontal, temporal, and parietal lobes; 
this tract has been implicated in the integration of these diverse regions involved in 
planning (Genova et al., 2013). Thus, my findings are congruent with previous work. 
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I found that difficulty with the motivation component of GDB is associated with 
atrophy in the OFC and related white matter tracts, including UNC (H3). Evidence from 
healthy subject fMRI studies suggests that the OFC plays a role in interpreting value- and 
reward-related information (Hare et al., 2010). In particular, evidence suggests that the 
medial OFC is more sensitive to reward signals and the lateral OFC is more sensitive to 
punishment signals (X. Liu, Hairston, Schrier, & Fan, 2011). Thus, the OFC encodes and 
assigns the relative value of reward for future decisions on avoidance or acquisition of the 
stimulus (S. I. Kim, 2013). Deficits in processing value and reward have been examined 
extensively in persons with FTD because they appear to have early degeneration of this 
frontal circuit in comparison to persons with other neurodegenerative conditions 
(Rabinovici et al., 2007). 
Poor motivation can occur in these individuals because they may have decreased 
reactivity to positive “reward” and negative “punishment” signals, thereby making goal-
selection difficult (Levy & Dubois, 2006). Experimental evidence, however, has 
emphasized that persons with bvFTD and other diseases affecting OFC have the greater 
difficulty interpreting “punishment” rather than “reward” signals (Grossman et al., 2010; 
Noonan, Kolling, Walton, & Rushworth, 2012). Imaging evidence from persons with 
bvFTD has emphasized the link between OFC and apathetic behavior (Massimo et al., 
2009). fludeoxyglucose PET brain activity is decreased in OFC in bvFTD patients with 
apathetic compared to nonapathetic patients (Peters et al., 2006). Apathy scores from the 
NPI have been associated with atrophy in ventromedial frontal regions (Rosen et al., 
2005). UNC is a major tract connecting the anterior temporal lobe with the medial and 
lateral prefrontal cortex (Papagno et al., 2011), areas known to be important for GDB 
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(Kable & Glimcher, 2007). DTI studies performed in AD and PSP implicated UNC in 
apathy (Hahn et al., 2013; Kvickstrom et al., 2011), and my results extend this finding to 
bvFTD. 
Three subtypes of apathy, based on differentiated impairments in GDB, exist 
in bvFTD (AIM 2, see Chapter 3). Consistent with the definition of apathy as the 
pathology of GDB, I studied a sample of apathetic bvFTD participants and identified 
individuals who demonstrated impairments on one or more components of GDB. 
Consider first the failure to initiate behavior, which leads to a subtype of apathy when 
processing is unable to generate a signal significant enough to begin a response. The 
initiation condition of the PACT assessed this GDB component quantitatively by 
measuring latency to initiate a movement in response to a visual signal. I found that some 
apathetic bvFTD participants were significantly impaired only on this component of 
GDB (H1). 
Initiation difficulty, however, was not the only basis for apathetic behavior. The 
ability to execute an action is also highly dependent on the cognitive processes needed to 
plan, organize, and carry out goals. Apathy related to “cognitive inertia” can result from 
impairments in executive functions such as planning, working memory, and task-
switching (Burgess, 2000; Levy & DuBois, 2006). I assessed two levels of task difficulty 
in the planning condition of the PACT. In the first level (simple planning condition), after 
depressing the start key, participants were signaled by randomly-ordered lateralized 
visual stimuli to press a left or right target key. In the second, more complex level, one of 
two lateralized keys were pressed, contingent on the combination of patterns in a central 
visual stimulus (blue and horizontal stripes go left, orange and vertical stripes go right). I 
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found that some apathetic participants were significantly impaired only on the planning 
condition (H2). Moreover, poor planning was the most prevalent single component of 
GDB found to be impaired in this bvFTD sample. This is not surprising, given that a 
dysexecutive neuropsychological profile is a common finding in bvFTD (Rascovsky et al., 
2011). Another component of GDB is motivation, that is, responsiveness to external and 
internal drives that may be perceived as positive or negative. Apathy may result from a 
lack of responsiveness to reward or risk, thereby making goal-selection difficult (Levy & 
Dubois, 2006; Rosen et al., 2002; Schultz et al., 2000). Likewise, reduced ability to 
assess and interpret consequences of actions, whether positive or negative, can limit 
motivation (Zamboni et al., 2008). Patients with bvFTD typically have a greater desire 
for certain rewards such as money, but tend to show insensitivity to negative 
consequences (Grossman et al., 2010; D. C. Perry et al., 2013). Therefore, I used a 
penalty condition (negative consequence) to assess impaired motivation. I found that 
participants performed faster on the simple reward condition (compared to the simple 
condition without incentive), suggesting they were motivated by the monetary incentive. 
Their performance pattern did not change, however, when I removed monetary units in 
response to not performing faster, suggesting an insensitivity to negative consequences. 
In my sample of bvFTD participants, I identified some individuals with single 
impairment in the motivational component of GDB (H3). Thus, the results support the 
presence of differentiated sources of apathy, including deficits in initiation, planning, and 
motivation that work together to limit GDB. 
Together, the analyses of Aims 1 and 2 support the model of apathy as a 
complex behavioral syndrome comprised of three distinct mechanisms related to 
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impairments in GDB, each with its own neuroanatomical basis. Using this model 
opens new avenues of approaches to managing or treating apathy. Most researchers of 
bvFTD have assumed that apathy is a single, undifferentiated behavioral phenomenon 
(Rosen et al., 2005, Zamboni et al., 2008). One early approach proposed defining an 
undifferentiated form of apathy as a lack of motivation (Marin, 1990), although lack of 
motivation does not appear to be the only mechanism that contributes to apathetic 
behavior. Others have suggested that apathy is related to impairment of other single 
processes such as difficulty with initiation (Tekin & Cummings, 2002). Subsequently, 
investigators proposed to define apathy as “the quantitative reduction of self-generated 
voluntary and purposeful behavior” (Levy & Dubois, 2006, 916). The model of GDB 
includes initiation, planning, and motivation (Brown & Pluck, 2000), which allow a 
person to direct purposeful behavior toward a desirable goal or away from an undesirable 
outcome (Geurts & de Wit, 2013). Although each process is necessary to achieve GDB, 
my research findings suggest these processes are, in fact, dissociable. For example, I 
found that apathetic bvFTD patients are impaired on one or more of the three processes 
thought to contribute to GDB: initiation, planning, and motivation. These three GDB 
processes were associated with disease in three distinct frontal grey matter regions and in 
white matter projections between these regions and other brain areas. Moreover, I found 
apathetic participants who demonstrated single deficits in only one of the three 
components of GDB. Indeed, apathy arises when any one of these three processes is 
impaired. For example, patients who have impairments in executive abilities needed to 
carry out plans of action may not find it difficult to initiate GDB or lack motivation, but 
their planning impairment may overwhelm their ability to develop plans of action that are 
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complex. My findings, thus, suggest that each GDB process is relatively independent and, 
when compromised, likely contributes to apathy. 
Implications for Practice 
This study examined a pathophysiological model of GDB, which revealed three 
distinct mechanisms likely contributing to apathy: impairments in initiation, planning, 
and motivation. A future goal is to optimize interventions for apathy subtypes based on 
an understanding of these mechanisms. The assessment of the efficacy of treatments for 
apathy has heretofore been hindered because of methodological failures in trials where 
apathetic patients are viewed homogeneously, for example solely as displaying a “lack of 
motivation.” I found that lack of motivation is not the only process that contributes to 
apathy. Based on my work, future treatments for apathy would more appropriately be 
tailored to the specific component(s) of GDB that is (are) compromised in an individual. 
Interventions should be explored based on the structural anatomic features of each of the 
three impairments in GDB. For example, when apathy emerges in response to planning 
difficulties, benefit may be gained from restructuring a complex activity into simple 
components for the patient. For patients with impaired goal-selection (motivation), 
modifications such as amplified lighting in a room or onto a specific activity or object 
may increase the reward potential of the environment (Ishii et al., 2009). Last, MSS—a 
therapeutic approach that provides visual, auditory, tactile and olfactory stimulation—
may be helpful for patients with initiation difficulty (Baker et al., 2001). The use of MSS 
in a patient with planning difficulty, however, may worsen rather than improve apathy 
because it can cause distractibility. To facilitate research, a systemic evaluation of 
existing interventions for apathy is warranted, followed by the categorization and testing 
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of interventions designed for specific subtypes. These studies are important to improve 
patient and caregiver quality of life. 
Recognizing and making a reliable diagnosis of apathy is essential to initiate 
treatment. Healthcare practitioners may overlook patients with apathy because of their 
lack of apparent distress (Butterfield et al., 2010). Although several apathy-assessment 
tools exist for the cognitively impaired population, researchers lack agreement on the 
interpretability of the data from these measures (Clarke et al., 2011). Traditional 
instruments to ascertain the presence of apathy commonly rely on proxy report. 
Unfortunately, this approach is subject to caregiver confounds such as burden and strain 
that may impact the evaluation. This dissertation study, along with others (Boyer et al., 
2004), has found that this approach is biased by caregiver stress. One goal of the present 
study was to identify subtypes of apathy in an objective manner, minimally confounded 
by proxy report. This study furthers the research in this area because I used an 
empirically-based approach that elucidated mechanisms contributing to apathy. This 
work is the first step in the development of an instrument that would be based on 
objective, empirical measurements of impairments of each of the components of GDB 
that contribute to apathy. Such an instrument would improve on the current instruments 
because of its objective basis and would increase the likelihood of detection and targeted 
treatment of specific subtypes of apathy. 
Implications for Social Neuroscience 
I propose, in short, that the syndrome of apathy is complex, consisting of 
impairments in at least one GDB process. As discussed above, these processes are largely 
independent of each other, rather than sequential or hierarchical, as has been suggested 
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by others (Dezfouli & Balleine, 2013; Levy & Dubois, 2006). My findings support the 
view that apathy is a conceptually heterogeneous syndrome, explained in part by 
underlying dysfunction at the neuroanatomical level. Figure 6 presents an illustration of 
my hypothesized model of apathy, adapted from Levy and DuBois (2006). 
 
Figure 6. Model of apathy as the pathology of goal-directed behavior in behavioral 
variant frontotemporal degeneration. 
Note. Adapted from “Apathy and the Functional Anatomy of the Prefrontal Cortex-Basal 
Ganglia Circuits,” by R. Levy & B. Dubois, 2006, Cerebral Cortex, 16, 918. 
doi:10.1093/cercor/bhj043 
Study Strengths 
Although apathy is a significant problem that is commonly observed in persons 
with bvFTD and has a pervasive impact on their caregivers, current understanding of 
apathy is based on observational data. This dissertation is the first study to examine 
apathy using the GDB model to guide direct, empirical assessments of behavior and 
interpretation of results. Overwhelmingly, the most common way to assess apathy has been 
through caregiver questionnaires. Caregiver surveys, however, do not assess apathy by directly 
ascertaining patient performance, thereby limiting their validity and reliability. Moreover, 
ascertainment of patient apathy solely from a caregiver’s perspective is likely to be confounded 
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by caregiver stress (Boyer et al., 2004). Indeed, I found a correlation between apathy symptom 
FxS scores and caregiver-distress scores on the NPI. Currently available instruments, such as 
the NPI, are less than optimal because they are also insensitive to subtypes of apathy (Chow et 
al., 2009). The PACT was developed as an alternate measure that provides a direct, 
independent assessment of GDB components contributing to apathy that is not biased by the 
subjectivity of caregiver-rated questionnaires. 
The method used in this dissertation, thus, offers several advantages over 
traditional, questionnaire-based approaches to measuring apathy because I directly 
ascertained participant performance without the intervening factor of a caregiver’s 
impression. Moreover, I assessed several different components of GDB that are believed 
to contribute to apathy. Although not a primary aim of the study, the study data served to 
provide validation for the PACT with a neuroanatomical model of apathy. I used VBM to 
quantify significant grey matter changes in this bvFTD sample and I related these 
changes to PACT performance. Based on previous literature reports in ND and lesion 
studies, I hypothesized that poor initiation was related to ACC disease (Kotchoubey et al., 
2003; Reijnders et al., 2010), poor executive function (planning) was related to disease in 
dlPFC (Kaller et al., 2011; Unterrainer, Rahm, Kaller, Ruff, et al., 2004), and reduced 
motivation was related to disease in the orbital and medial prefrontal cortex (Diekhof et 
al., 2011; Sescousse et al., 2010). These earlier findings were replicated in my 
dissertation data. My hypothesized anatomic model of apathy falls in the broad area in 
the frontal lobe that I had previously correlated with NPI FxS apathy scores (Massimo et 
al., 2009). Moreover, my assessment of white matter disease was the first to examine 
apathy in bvFTD comprehensively. The availability of both grey matter and white matter 
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neuroimaging data allowed me to investigate a large-scale neural network that subserves 
a complex behavior. This allowed me to develop a framework that captured the complex 
associations of impaired GDB encompassing the various subtypes of apathy and their 
associated neuroanatomic substrates, and to examine the ways the breakdown of this 
network can lead to the clinical syndrome of apathy. 
Study Limitations 
Several potential limitations should be kept in mind when considering these 
findings. Although the sample was larger than in prior investigations of apathy, I 
nevertheless studied a small number of participants; power in the imaging studies may 
not have been sufficient to detect every anatomic region associated with apathy. In 
addition, as anticipated, the participant sample was not diverse and querying the database 
to find a representative sample did not reveal additional women or diverse racial/ethnic 
participants. Because floor effects in performing the planning measure limited variance, I 
was forced to use a higher threshold for the grey matter analyses in Chapter 2. In addition, 
I had to adjust my planning subtype criteria in Chapter 3. Most participants with 
impairments in initiation and/or motivation also had a planning impairment, consistent 
with the dysexecutive profile typically seen in bvFTD (Rascovsky et al., 2011). To better 
classify participants with impaired planning, I implemented the application of the 
planning criteria for those with multiple impairments in a stepwise fashion. That is, I 
subjected planning-impaired participants who also had deficits in initiation and/or 
motivation to a second level review; I only classified participants who also had greater 
slowing on the complex planning condition compared to the simpler planning condition 
into the planning-impairment subtype. 
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Based on these considerations, however, it will be important in future studies to 
make the planning condition less complex by giving participants only two contingencies. 
Four participants with an isolated planning subtype were mildly impaired on the 
complex-planning condition (mean z-score = 2.52), but their difference score on the 
simpler planning condition compared to complex planning condition did not quite attain 
significance. Thus, it will be important in the future to study more patients with mild 
apathy to better characterize early behavioral changes. Additionally, I studied participants 
with mild ND (defined by MMSE score), and it would be valuable to extend assessment 
to participants with greater cognitive impairments. It would also be important to follow 
participants longitudinally to see if apathetic profiles are maintained throughout the 
duration of disease (see Aim 3, Chapter 4). I studied apathy in bvFTD particularly 
because it is very common in this condition; these patients do not have physical 
limitations that can confound the quantitative assessment of reduced GDB, and there are 
no language or visuospatial deficits that can potentially limit the interpretation of 
impaired performance. Nevertheless, it is important to investigate GDB in apathetic 
participants with other ND, like AD or PD, who also display apathy. 
Areas for Further Research 
This dissertation research study found that three distinct mechanisms, related to 
impairments in GDB, likely contribute to subtypes of apathy in bvFTD. As previously 
described, conceptualizing distinct subtypes of apathy may benefit the development of 
interventions tailored to mediate each compromised mechanism, but I must first 
understand the natural history of these impairments and the biological and environmental 
factors that influence the rate of their decline. The identification of factors that moderate 
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the clinical expression of disease, in this case apathy, is an important consideration for 
identifying persons “at risk” for more rapid decline and optimizing interventions for all 
persons with apathy associated with ND. Thus, my next research projects will examine 
how GDB impairments in apathetic bvFTD patients worsen over time (Aim 3, see 
Chapter 4). I plan to identify the influence of cognitive reserve factors such as 
environmental, genetic and anatomic influence on the rate of change in GDB 
impairments in apathetic persons with bvFTD. This will help me gain a better 
understanding of reserve mechanisms and their relationship to apathy, to determine who 
may be “at risk” for faster decline. With support from my Ruth L. Kirschstein National 
Research Service Award for Individual Postdoctoral Fellowships (F32; see Appendix B), 
this work will fill a crucial gap and will be used to develop treatment strategies and 
evaluate the effectiveness of tailored interventions. 
A number of participants (40%) were impaired on multiple components of GDB. 
Compared to individuals displaying a multicomponent subtype of apathy, those with a 
single GDB deficit did not differ by age, disease duration, MMSE or NPI FxS score (all 
p > .05), suggesting that I cannot easily attribute variations in apathetic difficulty to 
variability in the underlying disease process, but instead can relate them, in part, to 
anatomical distribution of disease. Additional work is needed to confirm this with larger 
groups of participants. 
A questionnaire instrument that measures each component of GDB, quantified by 
the PACT, may provide further validation for my hypothesized GDB model. As 
previously described, beyond confirming the presence of apathy, current instruments such 
as the NPI are ineffective in identifying different subtypes of apathy (Chow et al., 2009). 
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In fact, I did not find correlations between PACT scores (individual or composite) with 
either NPI caregiver-distress scores or NPI FxS apathy scores. This lack of finding 
provides support for the notion that the NPI assesses global apathy whereas the PACT 
assesses component of GDB that contribute to apathy. 
A necessary step is the development of an instrument that is based on my 
empirical measurements of impaired GDB. This type of instrument would increase the 
likelihood of detection and treatment of subtypes of apathy and, being specific to each 
component of GDB, may invite less respondent bias than do existing more general 
measures. Other instrumentation such as neuropsychological measures may also provide 
validation for my hypothesized model. I did not find significant correlations between the 
neuropsychological data available for my study and initiation and motivation measures 
from the PACT. This may be due, in part, to the lack of specificity for initiation and 
motivation constructs in currently available measures. 
I did observe some overlap across behavioral and neuroanatomical measures. For 
example, my grey matter observations suggested that the ACC may contribute to both 
initiation and motivation. In fact, post hoc correlation analyses of PACT measures 
revealed a significant correlation between initiation and motivation performance 
(rho = .78; p < .001). Post hoc correlations, however, are not significant between other 
PACT measures (all p > .05 Bonferroni corrected) and I otherwise observed distinct 
neuroanatomical regions contributing to components of GDB. It will be important for 
future work to identify quantitative measures of initiation and motivation that are not 
interdependent. 
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This study investigated the neural basis for apathy from a structural 
neuroanatomical viewpoint. Although voxel-based morphometry is the most commonly 
used approach to examine the anatomical basis of behavioral syndromes in ND, the 
measurement of brain activation using functional neuroimaging (fMRI) may be a 
complementary way of validating and increasing understanding of the GDB model. My 
findings suggest that GDB is supported by a large-scale neural network in distinct 
specific portions of the prefrontal cortex. A functional investigation of apathy may 
provide additional information regarding how each process of GDB interacts with 
another. Other technologies that measure function such as transcranial magnetic 
stimulation or actigraphy may be helpful in confirming the interaction of GDB processes. 
This can be done by examining distinctive patterns of cortical excitability or locomotive 
activity. In sum, apathy is a complex behavioral syndrome and multimodal methods 
should be adopted in future research to provide insight into the dynamic interrelationships 
between structure and function (Carey & Seitz, 2007). 
Conclusion 
GDB is a multicomponent process that involves initiation, planning, and 
motivation. These three GDB processes map onto three distinct brain regions that work 
together in a large-scale neural network. This network captures the information from 
internal and external environments needed for GDBs. Each frontal region is functionally 
separate in supporting initiation, planning, and motivation, but interacts with the others to 
mediate overall GDB. A specific GDB process suffers when one of these frontal areas is 
compromised, and is associated with behavior currently referenced as apathy. Presently, apathy 
is viewed as a unitary concept. This research has supported the view that apathy is a 
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multicomponent phenomenon—a complex behavioral syndrome that emerges when there is 
dysfunction in any GDB component. Thus, it is likely that the pathophysiology is not a single 
mechanism, but rather multifaceted, depending on which specific GDB process is impaired. 
Furthermore, it is possible to identify single impairments in GDB that may contribute to 
different clinical profiles or subtypes of apathy. GDB allows people to be independent in 
everyday task performance. This work will change the paradigm for assessing and treating 
apathy, leading to improved diagnostic accuracy and effective interventions to improve the 
ability of families, nurses, and other health professionals to manage a pervasive feature of ND. 
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